Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002526 | 0.00000 | 10.61723 | 2 | 16 | 212 | acute inflammatory response |
| GO:0007155 | 0.00000 | 3.72168 | 12 | 35 | 1370 | cell adhesion |
| GO:0022610 | 0.00000 | 3.70063 | 12 | 35 | 1377 | biological adhesion |
| GO:0002673 | 0.00000 | 9.94737 | 1 | 11 | 150 | regulation of acute inflammatory response |
| GO:0048731 | 0.00000 | 2.39667 | 39 | 68 | 4622 | system development |
| GO:0030449 | 0.00000 | 11.40373 | 1 | 9 | 107 | regulation of complement activation |
| GO:2000257 | 0.00000 | 11.28788 | 1 | 9 | 108 | regulation of protein activation cascade |
| GO:0006954 | 0.00000 | 3.98475 | 6 | 22 | 751 | inflammatory response |
| GO:0032101 | 0.00000 | 3.82029 | 7 | 22 | 781 | regulation of response to external stimulus |
| GO:0007275 | 0.00000 | 2.27264 | 44 | 72 | 5190 | multicellular organism development |
| GO:0006958 | 0.00000 | 9.70832 | 1 | 9 | 124 | complement activation, classical pathway |
| GO:0002920 | 0.00000 | 9.62406 | 1 | 9 | 125 | regulation of humoral immune response |
| GO:0070613 | 0.00000 | 7.99083 | 1 | 10 | 166 | regulation of protein processing |
| GO:1903317 | 0.00000 | 7.88876 | 1 | 10 | 168 | regulation of protein maturation |
| GO:0002455 | 0.00000 | 8.85507 | 1 | 9 | 135 | humoral immune response mediated by circulating immunoglobulin |
| GO:0009605 | 0.00000 | 2.55730 | 19 | 40 | 2238 | response to external stimulus |
| GO:0032502 | 0.00000 | 2.16412 | 52 | 79 | 6099 | developmental process |
| GO:0001952 | 0.00000 | 10.38334 | 1 | 8 | 103 | regulation of cell-matrix adhesion |
| GO:0048856 | 0.00000 | 2.16922 | 48 | 75 | 5666 | anatomical structure development |
| GO:0002449 | 0.00000 | 5.45765 | 3 | 13 | 314 | lymphocyte mediated immunity |
| GO:0002460 | 0.00000 | 5.45765 | 3 | 13 | 314 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045087 | 0.00000 | 3.37821 | 8 | 23 | 920 | innate immune response |
| GO:0023052 | 0.00000 | 2.12813 | 55 | 82 | 6496 | signaling |
| GO:0030155 | 0.00000 | 3.74528 | 6 | 19 | 676 | regulation of cell adhesion |
| GO:0007166 | 0.00000 | 2.36191 | 24 | 46 | 2832 | cell surface receptor signaling pathway |
| GO:0098609 | 0.00000 | 3.46460 | 7 | 21 | 812 | cell-cell adhesion |
| GO:0050727 | 0.00000 | 4.78451 | 3 | 14 | 385 | regulation of inflammatory response |
| GO:0007416 | 0.00001 | 7.90611 | 1 | 9 | 150 | synapse assembly |
| GO:0048646 | 0.00001 | 3.15088 | 9 | 24 | 1029 | anatomical structure formation involved in morphogenesis |
| GO:0002250 | 0.00001 | 4.20007 | 4 | 16 | 503 | adaptive immune response |
| GO:0034694 | 0.00001 | 23.30444 | 0 | 5 | 31 | response to prostaglandin |
| GO:0006952 | 0.00001 | 2.68378 | 14 | 32 | 1651 | defense response |
| GO:0016064 | 0.00001 | 6.72677 | 2 | 10 | 195 | immunoglobulin mediated immune response |
| GO:0045785 | 0.00001 | 4.66870 | 3 | 14 | 394 | positive regulation of cell adhesion |
| GO:0006955 | 0.00001 | 2.51363 | 18 | 37 | 2071 | immune response |
| GO:0006956 | 0.00001 | 7.63311 | 1 | 9 | 155 | complement activation |
| GO:0019724 | 0.00001 | 6.65405 | 2 | 10 | 197 | B cell mediated immunity |
| GO:0007160 | 0.00001 | 6.34515 | 2 | 10 | 206 | cell-matrix adhesion |
| GO:0120036 | 0.00001 | 2.76845 | 12 | 28 | 1378 | plasma membrane bounded cell projection organization |
| GO:0030030 | 0.00002 | 2.70529 | 12 | 28 | 1407 | cell projection organization |
| GO:0048583 | 0.00002 | 2.10497 | 34 | 57 | 4043 | regulation of response to stimulus |
| GO:0018108 | 0.00002 | 4.52165 | 3 | 13 | 375 | peptidyl-tyrosine phosphorylation |
| GO:0018212 | 0.00002 | 4.48368 | 3 | 13 | 378 | peptidyl-tyrosine modification |
| GO:0072376 | 0.00002 | 6.58541 | 2 | 9 | 178 | protein activation cascade |
| GO:0002443 | 0.00002 | 3.18490 | 7 | 20 | 832 | leukocyte mediated immunity |
| GO:0050896 | 0.00002 | 2.03398 | 74 | 99 | 8776 | response to stimulus |
| GO:0071379 | 0.00003 | 26.75369 | 0 | 4 | 22 | cellular response to prostaglandin stimulus |
| GO:0043408 | 0.00003 | 3.31556 | 6 | 18 | 714 | regulation of MAPK cascade |
| GO:0030154 | 0.00003 | 2.04932 | 34 | 56 | 4036 | cell differentiation |
| GO:0007045 | 0.00004 | 10.90314 | 1 | 6 | 73 | cell-substrate adherens junction assembly |
| GO:0048041 | 0.00004 | 10.90314 | 1 | 6 | 73 | focal adhesion assembly |
| GO:0009653 | 0.00004 | 2.24193 | 21 | 40 | 2503 | anatomical structure morphogenesis |
| GO:0048666 | 0.00004 | 2.89713 | 9 | 22 | 1009 | neuron development |
| GO:0007154 | 0.00004 | 1.94867 | 55 | 79 | 6516 | cell communication |
| GO:0001954 | 0.00004 | 14.76554 | 0 | 5 | 46 | positive regulation of cell-matrix adhesion |
| GO:0071229 | 0.00005 | 5.91327 | 2 | 9 | 197 | cellular response to acid chemical |
| GO:0042493 | 0.00005 | 4.10388 | 3 | 13 | 411 | response to drug |
| GO:0048869 | 0.00006 | 1.99676 | 36 | 57 | 4207 | cellular developmental process |
| GO:0031175 | 0.00006 | 2.97287 | 8 | 20 | 887 | neuron projection development |
| GO:0010562 | 0.00006 | 2.73381 | 9 | 23 | 1118 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00006 | 2.73381 | 9 | 23 | 1118 | positive regulation of phosphate metabolic process |
| GO:0030183 | 0.00006 | 7.71306 | 1 | 7 | 118 | B cell differentiation |
| GO:0048584 | 0.00007 | 2.24670 | 19 | 36 | 2210 | positive regulation of response to stimulus |
| GO:0002252 | 0.00007 | 2.66191 | 10 | 24 | 1201 | immune effector process |
| GO:0001970 | 0.00007 | Inf | 0 | 2 | 2 | positive regulation of activation of membrane attack complex |
| GO:2000040 | 0.00007 | Inf | 0 | 2 | 2 | regulation of planar cell polarity pathway involved in axis elongation |
| GO:2000041 | 0.00007 | Inf | 0 | 2 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
| GO:0034333 | 0.00007 | 9.48162 | 1 | 6 | 83 | adherens junction assembly |
| GO:0070542 | 0.00007 | 9.48162 | 1 | 6 | 83 | response to fatty acid |
| GO:0001775 | 0.00007 | 2.55075 | 12 | 26 | 1365 | cell activation |
| GO:0050808 | 0.00007 | 4.95883 | 2 | 10 | 260 | synapse organization |
| GO:0031589 | 0.00008 | 4.48937 | 3 | 11 | 316 | cell-substrate adhesion |
| GO:0001932 | 0.00008 | 2.52619 | 12 | 26 | 1377 | regulation of protein phosphorylation |
| GO:0016339 | 0.00009 | 20.05828 | 0 | 4 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0030162 | 0.00009 | 2.97128 | 7 | 19 | 839 | regulation of proteolysis |
| GO:0002684 | 0.00009 | 2.72935 | 9 | 22 | 1066 | positive regulation of immune system process |
| GO:0006959 | 0.00009 | 4.41565 | 3 | 11 | 321 | humoral immune response |
| GO:0007399 | 0.00009 | 2.20826 | 19 | 36 | 2243 | nervous system development |
| GO:0051893 | 0.00009 | 12.34909 | 0 | 5 | 54 | regulation of focal adhesion assembly |
| GO:0090109 | 0.00009 | 12.34909 | 0 | 5 | 54 | regulation of cell-substrate junction assembly |
| GO:2000403 | 0.00010 | 19.25483 | 0 | 4 | 29 | positive regulation of lymphocyte migration |
| GO:0001101 | 0.00010 | 4.37256 | 3 | 11 | 324 | response to acid chemical |
| GO:0071398 | 0.00010 | 12.10141 | 0 | 5 | 55 | cellular response to fatty acid |
| GO:0007044 | 0.00011 | 8.79313 | 1 | 6 | 89 | cell-substrate junction assembly |
| GO:0032501 | 0.00011 | 1.87543 | 62 | 85 | 7363 | multicellular organismal process |
| GO:0031347 | 0.00011 | 2.99982 | 7 | 18 | 784 | regulation of defense response |
| GO:0003401 | 0.00011 | 18.51318 | 0 | 4 | 30 | axis elongation |
| GO:0070372 | 0.00011 | 4.69199 | 2 | 10 | 274 | regulation of ERK1 and ERK2 cascade |
| GO:0019220 | 0.00012 | 2.32779 | 15 | 30 | 1740 | regulation of phosphate metabolic process |
| GO:1903391 | 0.00012 | 11.63462 | 0 | 5 | 57 | regulation of adherens junction organization |
| GO:0002376 | 0.00012 | 2.05642 | 25 | 43 | 2928 | immune system process |
| GO:0045600 | 0.00013 | 11.41443 | 0 | 5 | 58 | positive regulation of fat cell differentiation |
| GO:0006468 | 0.00013 | 2.25638 | 16 | 32 | 1924 | protein phosphorylation |
| GO:0051174 | 0.00013 | 2.30680 | 15 | 30 | 1754 | regulation of phosphorus metabolic process |
| GO:0009888 | 0.00014 | 2.24438 | 16 | 32 | 1933 | tissue development |
| GO:0061756 | 0.00015 | 17.18881 | 0 | 4 | 32 | leukocyte adhesion to vascular endothelial cell |
| GO:0030036 | 0.00016 | 3.26876 | 5 | 15 | 594 | actin cytoskeleton organization |
| GO:0090179 | 0.00016 | 35.88333 | 0 | 3 | 13 | planar cell polarity pathway involved in neural tube closure |
| GO:0002697 | 0.00016 | 3.83909 | 3 | 12 | 402 | regulation of immune effector process |
| GO:0050730 | 0.00017 | 4.95245 | 2 | 9 | 233 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0048513 | 0.00018 | 1.97122 | 28 | 47 | 3365 | animal organ development |
| GO:0070371 | 0.00018 | 4.41971 | 2 | 10 | 290 | ERK1 and ERK2 cascade |
| GO:0090178 | 0.00020 | 32.61932 | 0 | 3 | 14 | regulation of establishment of planar polarity involved in neural tube closure |
| GO:0010810 | 0.00021 | 5.42247 | 2 | 8 | 189 | regulation of cell-substrate adhesion |
| GO:0010165 | 0.00021 | 15.52267 | 0 | 4 | 35 | response to X-ray |
| GO:0001905 | 0.00021 | 237.69655 | 0 | 2 | 3 | activation of membrane attack complex |
| GO:0001969 | 0.00021 | 237.69655 | 0 | 2 | 3 | regulation of activation of membrane attack complex |
| GO:0045917 | 0.00021 | 237.69655 | 0 | 2 | 3 | positive regulation of complement activation |
| GO:2000259 | 0.00021 | 237.69655 | 0 | 2 | 3 | positive regulation of protein activation cascade |
| GO:0000165 | 0.00023 | 2.73889 | 8 | 19 | 905 | MAPK cascade |
| GO:0030029 | 0.00023 | 3.01953 | 6 | 16 | 686 | actin filament-based process |
| GO:0048519 | 0.00023 | 1.83970 | 44 | 64 | 5154 | negative regulation of biological process |
| GO:0023057 | 0.00025 | 2.42587 | 11 | 24 | 1307 | negative regulation of signaling |
| GO:0060026 | 0.00025 | 29.89931 | 0 | 3 | 15 | convergent extension |
| GO:0090177 | 0.00025 | 29.89931 | 0 | 3 | 15 | establishment of planar polarity involved in neural tube closure |
| GO:0051604 | 0.00027 | 3.86792 | 3 | 11 | 364 | protein maturation |
| GO:0048514 | 0.00027 | 3.23563 | 5 | 14 | 557 | blood vessel morphogenesis |
| GO:0010212 | 0.00028 | 6.01831 | 1 | 7 | 149 | response to ionizing radiation |
| GO:0016485 | 0.00028 | 4.17686 | 3 | 10 | 306 | protein processing |
| GO:0048878 | 0.00028 | 2.55592 | 9 | 21 | 1076 | chemical homeostasis |
| GO:0007167 | 0.00028 | 2.61759 | 8 | 20 | 998 | enzyme linked receptor protein signaling pathway |
| GO:0023051 | 0.00029 | 1.92290 | 29 | 47 | 3432 | regulation of signaling |
| GO:0006928 | 0.00029 | 2.14496 | 17 | 32 | 2011 | movement of cell or subcellular component |
| GO:0071396 | 0.00033 | 3.16930 | 5 | 14 | 568 | cellular response to lipid |
| GO:0042325 | 0.00034 | 2.29405 | 13 | 26 | 1502 | regulation of phosphorylation |
| GO:0031399 | 0.00034 | 2.19684 | 15 | 29 | 1763 | regulation of protein modification process |
| GO:0023014 | 0.00034 | 2.64433 | 8 | 19 | 935 | signal transduction by protein phosphorylation |
| GO:0034329 | 0.00035 | 5.00308 | 2 | 8 | 204 | cell junction assembly |
| GO:0001568 | 0.00035 | 3.01982 | 5 | 15 | 640 | blood vessel development |
| GO:0120035 | 0.00036 | 3.14582 | 5 | 14 | 572 | regulation of plasma membrane bounded cell projection organization |
| GO:0042249 | 0.00037 | 25.62500 | 0 | 3 | 17 | establishment of planar polarity of embryonic epithelium |
| GO:0009967 | 0.00037 | 2.27717 | 13 | 26 | 1512 | positive regulation of signal transduction |
| GO:0007165 | 0.00038 | 1.77991 | 51 | 71 | 6003 | signal transduction |
| GO:0048518 | 0.00040 | 1.78256 | 48 | 68 | 5680 | positive regulation of biological process |
| GO:0050776 | 0.00040 | 2.54303 | 9 | 20 | 1025 | regulation of immune response |
| GO:0001934 | 0.00042 | 2.59933 | 8 | 19 | 950 | positive regulation of protein phosphorylation |
| GO:0090244 | 0.00042 | 118.84138 | 0 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
| GO:0097368 | 0.00042 | 118.84138 | 0 | 2 | 4 | establishment of Sertoli cell barrier |
| GO:0002682 | 0.00043 | 2.25555 | 13 | 26 | 1525 | regulation of immune system process |
| GO:0031344 | 0.00043 | 3.08297 | 5 | 14 | 583 | regulation of cell projection organization |
| GO:1905276 | 0.00044 | 23.91528 | 0 | 3 | 18 | regulation of epithelial tube formation |
| GO:0048870 | 0.00044 | 2.24898 | 13 | 26 | 1529 | cell motility |
| GO:0051674 | 0.00044 | 2.24898 | 13 | 26 | 1529 | localization of cell |
| GO:0048468 | 0.00045 | 2.10802 | 17 | 31 | 1970 | cell development |
| GO:0080134 | 0.00047 | 2.27337 | 12 | 25 | 1450 | regulation of response to stress |
| GO:1904994 | 0.00052 | 22.41927 | 0 | 3 | 19 | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0031401 | 0.00053 | 2.37934 | 10 | 22 | 1209 | positive regulation of protein modification process |
| GO:0045321 | 0.00055 | 2.37075 | 10 | 22 | 1213 | leukocyte activation |
| GO:0001944 | 0.00055 | 2.88087 | 6 | 15 | 669 | vasculature development |
| GO:0010648 | 0.00059 | 2.31188 | 11 | 23 | 1303 | negative regulation of cell communication |
| GO:0016477 | 0.00060 | 2.26842 | 12 | 24 | 1389 | cell migration |
| GO:0048699 | 0.00060 | 2.26842 | 12 | 24 | 1389 | generation of neurons |
| GO:2000401 | 0.00061 | 11.44988 | 0 | 4 | 46 | regulation of lymphocyte migration |
| GO:0010647 | 0.00061 | 2.16566 | 14 | 27 | 1649 | positive regulation of cell communication |
| GO:0055080 | 0.00062 | 2.84916 | 6 | 15 | 676 | cation homeostasis |
| GO:0055082 | 0.00062 | 2.74560 | 6 | 16 | 750 | cellular chemical homeostasis |
| GO:0034332 | 0.00062 | 6.22550 | 1 | 6 | 123 | adherens junction organization |
| GO:0072358 | 0.00062 | 2.84469 | 6 | 15 | 677 | cardiovascular system development |
| GO:0001525 | 0.00065 | 3.26321 | 4 | 12 | 469 | angiogenesis |
| GO:0023056 | 0.00065 | 2.15685 | 14 | 27 | 1655 | positive regulation of signaling |
| GO:1901888 | 0.00065 | 7.84571 | 1 | 5 | 82 | regulation of cell junction assembly |
| GO:0050801 | 0.00065 | 2.73005 | 6 | 16 | 754 | ion homeostasis |
| GO:0030003 | 0.00066 | 2.94879 | 5 | 14 | 608 | cellular cation homeostasis |
| GO:0022008 | 0.00066 | 2.21727 | 13 | 25 | 1483 | neurogenesis |
| GO:0050732 | 0.00066 | 11.18296 | 0 | 4 | 47 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0033993 | 0.00066 | 2.56242 | 8 | 18 | 908 | response to lipid |
| GO:0007584 | 0.00068 | 5.14096 | 1 | 7 | 173 | response to nutrient |
| GO:1903039 | 0.00068 | 4.49238 | 2 | 8 | 226 | positive regulation of leukocyte cell-cell adhesion |
| GO:0022614 | 0.00070 | 79.22299 | 0 | 2 | 5 | membrane to membrane docking |
| GO:0071798 | 0.00070 | 79.22299 | 0 | 2 | 5 | response to prostaglandin D |
| GO:0071799 | 0.00070 | 79.22299 | 0 | 2 | 5 | cellular response to prostaglandin D stimulus |
| GO:1904956 | 0.00070 | 79.22299 | 0 | 2 | 5 | regulation of midbrain dopaminergic neuron differentiation |
| GO:2000051 | 0.00070 | 79.22299 | 0 | 2 | 5 | negative regulation of non-canonical Wnt signaling pathway |
| GO:0050901 | 0.00070 | 19.92593 | 0 | 3 | 21 | leukocyte tethering or rolling |
| GO:0042327 | 0.00072 | 2.47802 | 8 | 19 | 993 | positive regulation of phosphorylation |
| GO:0035239 | 0.00075 | 3.65982 | 3 | 10 | 347 | tube morphogenesis |
| GO:0098771 | 0.00076 | 2.78771 | 6 | 15 | 690 | inorganic ion homeostasis |
| GO:0040011 | 0.00077 | 2.10326 | 15 | 28 | 1762 | locomotion |
| GO:0002521 | 0.00078 | 3.19143 | 4 | 12 | 479 | leukocyte differentiation |
| GO:0060429 | 0.00078 | 2.30412 | 11 | 22 | 1245 | epithelium development |
| GO:0010954 | 0.00081 | 18.87610 | 0 | 3 | 22 | positive regulation of protein processing |
| GO:1901655 | 0.00081 | 7.45653 | 1 | 5 | 86 | cellular response to ketone |
| GO:0006873 | 0.00082 | 2.87846 | 5 | 14 | 622 | cellular ion homeostasis |
| GO:0022603 | 0.00082 | 2.44869 | 8 | 19 | 1004 | regulation of anatomical structure morphogenesis |
| GO:0045216 | 0.00083 | 4.35082 | 2 | 8 | 233 | cell-cell junction organization |
| GO:0045123 | 0.00084 | 10.45181 | 0 | 4 | 50 | cellular extravasation |
| GO:0001843 | 0.00086 | 7.36517 | 1 | 5 | 87 | neural tube closure |
| GO:0051128 | 0.00087 | 1.96054 | 20 | 34 | 2327 | regulation of cellular component organization |
| GO:0051094 | 0.00087 | 2.28201 | 11 | 22 | 1256 | positive regulation of developmental process |
| GO:0060606 | 0.00090 | 7.27601 | 1 | 5 | 88 | tube closure |
| GO:0016043 | 0.00091 | 1.70823 | 51 | 70 | 6056 | cellular component organization |
| GO:0030182 | 0.00091 | 2.27407 | 11 | 22 | 1260 | neuron differentiation |
| GO:0098742 | 0.00098 | 4.23632 | 2 | 8 | 239 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0022407 | 0.00099 | 3.28609 | 4 | 11 | 425 | regulation of cell-cell adhesion |
| GO:0006796 | 0.00100 | 1.83011 | 27 | 43 | 3219 | phosphate-containing compound metabolic process |
| GO:0051336 | 0.00102 | 2.29674 | 10 | 21 | 1187 | regulation of hydrolase activity |
| GO:0032270 | 0.00102 | 2.14319 | 13 | 25 | 1529 | positive regulation of cellular protein metabolic process |
| GO:0003402 | 0.00104 | 59.41379 | 0 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
| GO:0000768 | 0.00104 | 9.81019 | 0 | 4 | 53 | syncytium formation by plasma membrane fusion |
| GO:0002691 | 0.00105 | 17.07639 | 0 | 3 | 24 | regulation of cellular extravasation |
| GO:0034695 | 0.00105 | 17.07639 | 0 | 3 | 24 | response to prostaglandin E |
| GO:1903319 | 0.00105 | 17.07639 | 0 | 3 | 24 | positive regulation of protein maturation |
| GO:2000406 | 0.00105 | 17.07639 | 0 | 3 | 24 | positive regulation of T cell migration |
| GO:0051246 | 0.00106 | 1.85391 | 25 | 40 | 2932 | regulation of protein metabolic process |
| GO:0048608 | 0.00107 | 3.25387 | 4 | 11 | 429 | reproductive structure development |
| GO:0072676 | 0.00110 | 6.93986 | 1 | 5 | 92 | lymphocyte migration |
| GO:0048523 | 0.00113 | 1.72664 | 40 | 57 | 4682 | negative regulation of cellular process |
| GO:0061458 | 0.00113 | 3.23011 | 4 | 11 | 432 | reproductive system development |
| GO:0070588 | 0.00117 | 3.73193 | 3 | 9 | 305 | calcium ion transmembrane transport |
| GO:0097305 | 0.00117 | 4.65874 | 2 | 7 | 190 | response to alcohol |
| GO:0042127 | 0.00118 | 2.08953 | 14 | 26 | 1633 | regulation of cell proliferation |
| GO:0040007 | 0.00118 | 2.42689 | 8 | 18 | 955 | growth |
| GO:0006949 | 0.00120 | 9.42438 | 0 | 4 | 55 | syncytium formation |
| GO:0014020 | 0.00121 | 6.78311 | 1 | 5 | 94 | primary neural tube formation |
| GO:0060562 | 0.00131 | 3.66886 | 3 | 9 | 310 | epithelial tube morphogenesis |
| GO:0043410 | 0.00133 | 2.98724 | 4 | 12 | 510 | positive regulation of MAPK cascade |
| GO:0006935 | 0.00135 | 2.84139 | 5 | 13 | 582 | chemotaxis |
| GO:0042330 | 0.00135 | 2.84139 | 5 | 13 | 582 | taxis |
| GO:0032845 | 0.00145 | 4.48526 | 2 | 7 | 197 | negative regulation of homeostatic process |
| GO:0060028 | 0.00145 | 47.52828 | 0 | 2 | 7 | convergent extension involved in axis elongation |
| GO:1903236 | 0.00145 | 47.52828 | 0 | 2 | 7 | regulation of leukocyte tethering or rolling |
| GO:0051251 | 0.00146 | 3.60784 | 3 | 9 | 315 | positive regulation of lymphocyte activation |
| GO:0008284 | 0.00150 | 2.43606 | 8 | 17 | 895 | positive regulation of cell proliferation |
| GO:0070374 | 0.00153 | 4.43802 | 2 | 7 | 199 | positive regulation of ERK1 and ERK2 cascade |
| GO:0048247 | 0.00156 | 8.73694 | 0 | 4 | 59 | lymphocyte chemotaxis |
| GO:0055065 | 0.00157 | 2.79065 | 5 | 13 | 592 | metal ion homeostasis |
| GO:0016310 | 0.00161 | 1.89572 | 20 | 33 | 2316 | phosphorylation |
| GO:0022409 | 0.00164 | 3.89418 | 2 | 8 | 259 | positive regulation of cell-cell adhesion |
| GO:0048585 | 0.00164 | 2.09401 | 13 | 24 | 1493 | negative regulation of response to stimulus |
| GO:0051179 | 0.00167 | 1.65327 | 54 | 72 | 6403 | localization |
| GO:0006875 | 0.00173 | 2.89148 | 4 | 12 | 526 | cellular metal ion homeostasis |
| GO:0070838 | 0.00174 | 3.05154 | 4 | 11 | 456 | divalent metal ion transport |
| GO:0001841 | 0.00174 | 6.22078 | 1 | 5 | 102 | neural tube formation |
| GO:0006793 | 0.00176 | 1.76829 | 28 | 43 | 3309 | phosphorus metabolic process |
| GO:0035556 | 0.00178 | 1.82746 | 23 | 37 | 2716 | intracellular signal transduction |
| GO:0043552 | 0.00184 | 13.78846 | 0 | 3 | 29 | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:0071295 | 0.00184 | 13.78846 | 0 | 3 | 29 | cellular response to vitamin |
| GO:0072511 | 0.00186 | 3.02363 | 4 | 11 | 460 | divalent inorganic cation transport |
| GO:0034330 | 0.00189 | 3.80192 | 2 | 8 | 265 | cell junction organization |
| GO:0045862 | 0.00190 | 3.21149 | 3 | 10 | 393 | positive regulation of proteolysis |
| GO:0060560 | 0.00192 | 4.25850 | 2 | 7 | 207 | developmental growth involved in morphogenesis |
| GO:0030098 | 0.00192 | 3.45816 | 3 | 9 | 328 | lymphocyte differentiation |
| GO:0002291 | 0.00192 | 39.60460 | 0 | 2 | 8 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0007172 | 0.00192 | 39.60460 | 0 | 2 | 8 | signal complex assembly |
| GO:2000427 | 0.00192 | 39.60460 | 0 | 2 | 8 | positive regulation of apoptotic cell clearance |
| GO:0046649 | 0.00195 | 2.61046 | 6 | 14 | 682 | lymphocyte activation |
| GO:0050793 | 0.00200 | 1.85254 | 21 | 34 | 2442 | regulation of developmental process |
| GO:0034097 | 0.00201 | 2.30431 | 8 | 18 | 1002 | response to cytokine |
| GO:0009612 | 0.00208 | 4.19483 | 2 | 7 | 210 | response to mechanical stimulus |
| GO:0045444 | 0.00208 | 4.19483 | 2 | 7 | 210 | fat cell differentiation |
| GO:0010811 | 0.00215 | 5.91411 | 1 | 5 | 107 | positive regulation of cell-substrate adhesion |
| GO:0042113 | 0.00218 | 3.71387 | 2 | 8 | 271 | B cell activation |
| GO:0007156 | 0.00219 | 4.81415 | 1 | 6 | 157 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0051247 | 0.00220 | 2.01479 | 14 | 25 | 1616 | positive regulation of protein metabolic process |
| GO:0030198 | 0.00222 | 3.38250 | 3 | 9 | 335 | extracellular matrix organization |
| GO:0050900 | 0.00223 | 2.94939 | 4 | 11 | 471 | leukocyte migration |
| GO:0042462 | 0.00224 | 12.80208 | 0 | 3 | 31 | eye photoreceptor cell development |
| GO:2000404 | 0.00224 | 12.80208 | 0 | 3 | 31 | regulation of T cell migration |
| GO:0043062 | 0.00226 | 3.37196 | 3 | 9 | 336 | extracellular structure organization |
| GO:0045765 | 0.00228 | 3.68541 | 2 | 8 | 273 | regulation of angiogenesis |
| GO:0007169 | 0.00229 | 2.56254 | 6 | 14 | 694 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0061564 | 0.00231 | 2.93627 | 4 | 11 | 473 | axon development |
| GO:0032970 | 0.00235 | 3.35106 | 3 | 9 | 338 | regulation of actin filament-based process |
| GO:0090218 | 0.00246 | 12.35991 | 0 | 3 | 32 | positive regulation of lipid kinase activity |
| GO:0051974 | 0.00246 | 33.94483 | 0 | 2 | 9 | negative regulation of telomerase activity |
| GO:1904996 | 0.00246 | 33.94483 | 0 | 2 | 9 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:1901701 | 0.00247 | 2.25802 | 9 | 18 | 1021 | cellular response to oxygen-containing compound |
| GO:0006816 | 0.00249 | 3.08770 | 3 | 10 | 408 | calcium ion transport |
| GO:0071840 | 0.00252 | 1.61952 | 53 | 70 | 6266 | cellular component organization or biogenesis |
| GO:0008406 | 0.00257 | 4.03389 | 2 | 7 | 218 | gonad development |
| GO:1903037 | 0.00260 | 3.29992 | 3 | 9 | 343 | regulation of leukocyte cell-cell adhesion |
| GO:0071300 | 0.00263 | 7.50437 | 1 | 4 | 68 | cellular response to retinoic acid |
| GO:0009968 | 0.00265 | 2.14840 | 10 | 20 | 1197 | negative regulation of signal transduction |
| GO:0032456 | 0.00269 | 11.94722 | 0 | 3 | 33 | endocytic recycling |
| GO:0007010 | 0.00270 | 2.14448 | 10 | 20 | 1199 | cytoskeleton organization |
| GO:0010646 | 0.00272 | 1.71995 | 29 | 43 | 3383 | regulation of cell communication |
| GO:0006874 | 0.00272 | 3.04849 | 3 | 10 | 413 | cellular calcium ion homeostasis |
| GO:0021954 | 0.00277 | 7.38849 | 1 | 4 | 69 | central nervous system neuron development |
| GO:0002696 | 0.00280 | 3.26010 | 3 | 9 | 347 | positive regulation of leukocyte activation |
| GO:0045137 | 0.00299 | 3.92097 | 2 | 7 | 224 | development of primary sexual characteristics |
| GO:0009966 | 0.00299 | 1.73435 | 26 | 40 | 3096 | regulation of signal transduction |
| GO:1904338 | 0.00306 | 29.70000 | 0 | 2 | 10 | regulation of dopaminergic neuron differentiation |
| GO:0001501 | 0.00307 | 2.82313 | 4 | 11 | 491 | skeletal system development |
| GO:0044089 | 0.00317 | 2.81108 | 4 | 11 | 493 | positive regulation of cellular component biogenesis |
| GO:0070555 | 0.00317 | 5.38292 | 1 | 5 | 117 | response to interleukin-1 |
| GO:0055074 | 0.00328 | 2.96555 | 4 | 10 | 424 | calcium ion homeostasis |
| GO:0010975 | 0.00334 | 2.95823 | 4 | 10 | 425 | regulation of neuron projection development |
| GO:0002685 | 0.00335 | 4.40206 | 1 | 6 | 171 | regulation of leukocyte migration |
| GO:0021953 | 0.00335 | 4.40206 | 1 | 6 | 171 | central nervous system neuron differentiation |
| GO:0031667 | 0.00340 | 2.95094 | 4 | 10 | 426 | response to nutrient levels |
| GO:0045598 | 0.00341 | 5.28787 | 1 | 5 | 119 | regulation of fat cell differentiation |
| GO:0006897 | 0.00344 | 2.44264 | 6 | 14 | 726 | endocytosis |
| GO:0033280 | 0.00345 | 10.85922 | 0 | 3 | 36 | response to vitamin D |
| GO:2000279 | 0.00345 | 10.85922 | 0 | 3 | 36 | negative regulation of DNA biosynthetic process |
| GO:0050867 | 0.00351 | 3.14609 | 3 | 9 | 359 | positive regulation of cell activation |
| GO:0019725 | 0.00352 | 2.28899 | 8 | 16 | 889 | cellular homeostasis |
| GO:0007267 | 0.00353 | 1.96186 | 13 | 24 | 1583 | cell-cell signaling |
| GO:0008283 | 0.00356 | 1.85205 | 17 | 29 | 2048 | cell proliferation |
| GO:0032956 | 0.00358 | 3.41058 | 2 | 8 | 294 | regulation of actin cytoskeleton organization |
| GO:0035295 | 0.00368 | 2.62246 | 5 | 12 | 577 | tube development |
| GO:2000425 | 0.00372 | 26.39847 | 0 | 2 | 11 | regulation of apoptotic cell clearance |
| GO:0022604 | 0.00375 | 2.90795 | 4 | 10 | 432 | regulation of cell morphogenesis |
| GO:0006950 | 0.00376 | 1.65765 | 33 | 47 | 3854 | response to stress |
| GO:0001838 | 0.00379 | 5.15138 | 1 | 5 | 122 | embryonic epithelial tube formation |
| GO:0110053 | 0.00380 | 3.74604 | 2 | 7 | 234 | regulation of actin filament organization |
| GO:1902533 | 0.00380 | 2.21193 | 8 | 17 | 979 | positive regulation of intracellular signal transduction |
| GO:0031032 | 0.00386 | 4.27134 | 1 | 6 | 176 | actomyosin structure organization |
| GO:0006811 | 0.00388 | 1.94538 | 13 | 24 | 1595 | ion transport |
| GO:0002687 | 0.00393 | 5.10742 | 1 | 5 | 123 | positive regulation of leukocyte migration |
| GO:0045834 | 0.00393 | 5.10742 | 1 | 5 | 123 | positive regulation of lipid metabolic process |
| GO:0009617 | 0.00394 | 2.59867 | 5 | 12 | 582 | response to bacterium |
| GO:0045597 | 0.00405 | 2.25361 | 8 | 16 | 902 | positive regulation of cell differentiation |
| GO:0072503 | 0.00413 | 2.86616 | 4 | 10 | 438 | cellular divalent inorganic cation homeostasis |
| GO:0065009 | 0.00422 | 1.67826 | 28 | 42 | 3359 | regulation of molecular function |
| GO:0071345 | 0.00427 | 2.24028 | 8 | 16 | 907 | cellular response to cytokine stimulus |
| GO:0051716 | 0.00428 | 1.56752 | 62 | 78 | 7299 | cellular response to stimulus |
| GO:0043687 | 0.00433 | 2.84570 | 4 | 10 | 441 | post-translational protein modification |
| GO:0030208 | 0.00444 | 23.75724 | 0 | 2 | 12 | dermatan sulfate biosynthetic process |
| GO:0042118 | 0.00444 | 23.75724 | 0 | 2 | 12 | endothelial cell activation |
| GO:0044092 | 0.00446 | 2.08188 | 10 | 19 | 1166 | negative regulation of molecular function |
| GO:1902903 | 0.00446 | 3.28213 | 3 | 8 | 305 | regulation of supramolecular fiber organization |
| GO:0046849 | 0.00452 | 6.39963 | 1 | 4 | 79 | bone remodeling |
| GO:0007159 | 0.00458 | 3.01412 | 3 | 9 | 374 | leukocyte cell-cell adhesion |
| GO:1901342 | 0.00464 | 3.25979 | 3 | 8 | 307 | regulation of vasculature development |
| GO:0007520 | 0.00466 | 9.68300 | 0 | 3 | 40 | myoblast fusion |
| GO:0031670 | 0.00466 | 9.68300 | 0 | 3 | 40 | cellular response to nutrient |
| GO:0042461 | 0.00466 | 9.68300 | 0 | 3 | 40 | photoreceptor cell development |
| GO:0002694 | 0.00466 | 2.66307 | 4 | 11 | 519 | regulation of leukocyte activation |
| GO:0008037 | 0.00467 | 4.10073 | 2 | 6 | 183 | cell recognition |
| GO:0051053 | 0.00481 | 4.85859 | 1 | 5 | 129 | negative regulation of DNA metabolic process |
| GO:0070098 | 0.00494 | 6.23268 | 1 | 4 | 81 | chemokine-mediated signaling pathway |
| GO:0072175 | 0.00497 | 4.81944 | 1 | 5 | 130 | epithelial tube formation |
| GO:0072359 | 0.00503 | 2.14567 | 9 | 17 | 1007 | circulatory system development |
| GO:0006810 | 0.00503 | 1.58115 | 43 | 58 | 5088 | transport |
| GO:1901654 | 0.00505 | 4.03168 | 2 | 6 | 186 | response to ketone |
| GO:0002520 | 0.00505 | 2.19861 | 8 | 16 | 923 | immune system development |
| GO:0007162 | 0.00520 | 3.52552 | 2 | 7 | 248 | negative regulation of cell adhesion |
| GO:1902531 | 0.00521 | 1.85047 | 15 | 26 | 1819 | regulation of intracellular signal transduction |
| GO:0001771 | 0.00521 | 21.59624 | 0 | 2 | 13 | immunological synapse formation |
| GO:0030205 | 0.00521 | 21.59624 | 0 | 2 | 13 | dermatan sulfate metabolic process |
| GO:0042976 | 0.00521 | 21.59624 | 0 | 2 | 13 | activation of Janus kinase activity |
| GO:0071481 | 0.00521 | 21.59624 | 0 | 2 | 13 | cellular response to X-ray |
| GO:2000095 | 0.00521 | 21.59624 | 0 | 2 | 13 | regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0002366 | 0.00525 | 2.40217 | 6 | 13 | 682 | leukocyte activation involved in immune response |
| GO:0000902 | 0.00526 | 2.18842 | 8 | 16 | 927 | cell morphogenesis |
| GO:0001754 | 0.00535 | 9.18536 | 0 | 3 | 42 | eye photoreceptor cell differentiation |
| GO:0043551 | 0.00535 | 9.18536 | 0 | 3 | 42 | regulation of phosphatidylinositol 3-kinase activity |
| GO:1903727 | 0.00535 | 9.18536 | 0 | 3 | 42 | positive regulation of phospholipid metabolic process |
| GO:0051249 | 0.00537 | 2.75388 | 4 | 10 | 455 | regulation of lymphocyte activation |
| GO:0072507 | 0.00546 | 2.74754 | 4 | 10 | 456 | divalent inorganic cation homeostasis |
| GO:0032496 | 0.00550 | 3.16285 | 3 | 8 | 316 | response to lipopolysaccharide |
| GO:0048511 | 0.00550 | 3.16285 | 3 | 8 | 316 | rhythmic process |
| GO:0002263 | 0.00551 | 2.38732 | 6 | 13 | 686 | cell activation involved in immune response |
| GO:0009991 | 0.00554 | 2.74123 | 4 | 10 | 457 | response to extracellular stimulus |
| GO:0051493 | 0.00554 | 2.74123 | 4 | 10 | 457 | regulation of cytoskeleton organization |
| GO:0034446 | 0.00562 | 5.99790 | 1 | 4 | 84 | substrate adhesion-dependent cell spreading |
| GO:0042542 | 0.00564 | 4.66890 | 1 | 5 | 134 | response to hydrogen peroxide |
| GO:0007528 | 0.00571 | 8.95521 | 0 | 3 | 43 | neuromuscular junction development |
| GO:0044087 | 0.00574 | 2.22616 | 7 | 15 | 852 | regulation of cellular component biogenesis |
| GO:0048522 | 0.00596 | 1.56769 | 42 | 57 | 5016 | positive regulation of cellular process |
| GO:0032989 | 0.00598 | 2.10502 | 9 | 17 | 1025 | cellular component morphogenesis |
| GO:0002693 | 0.00605 | 19.79540 | 0 | 2 | 14 | positive regulation of cellular extravasation |
| GO:0006957 | 0.00605 | 19.79540 | 0 | 2 | 14 | complement activation, alternative pathway |
| GO:0060009 | 0.00605 | 19.79540 | 0 | 2 | 14 | Sertoli cell development |
| GO:0030038 | 0.00610 | 5.85093 | 1 | 4 | 86 | contractile actin filament bundle assembly |
| GO:0043149 | 0.00610 | 5.85093 | 1 | 4 | 86 | stress fiber assembly |
| GO:0016192 | 0.00627 | 1.80200 | 16 | 27 | 1940 | vesicle-mediated transport |
| GO:0051963 | 0.00635 | 5.78010 | 1 | 4 | 87 | regulation of synapse assembly |
| GO:0030001 | 0.00657 | 2.19037 | 7 | 15 | 865 | metal ion transport |
| GO:0008584 | 0.00657 | 4.49338 | 1 | 5 | 139 | male gonad development |
| GO:0008285 | 0.00665 | 2.32963 | 6 | 13 | 702 | negative regulation of cell proliferation |
| GO:0009725 | 0.00670 | 2.18497 | 7 | 15 | 867 | response to hormone |
| GO:0046546 | 0.00677 | 4.45983 | 1 | 5 | 140 | development of primary male sexual characteristics |
| GO:0048145 | 0.00688 | 5.64344 | 1 | 4 | 89 | regulation of fibroblast proliferation |
| GO:0060333 | 0.00688 | 5.64344 | 1 | 4 | 89 | interferon-gamma-mediated signaling pathway |
| GO:0050766 | 0.00690 | 8.32897 | 0 | 3 | 46 | positive regulation of phagocytosis |
| GO:0098657 | 0.00692 | 2.24157 | 7 | 14 | 787 | import into cell |
| GO:0002922 | 0.00694 | 18.27162 | 0 | 2 | 15 | positive regulation of humoral immune response |
| GO:0010919 | 0.00694 | 18.27162 | 0 | 2 | 15 | regulation of inositol phosphate biosynthetic process |
| GO:0050651 | 0.00694 | 18.27162 | 0 | 2 | 15 | dermatan sulfate proteoglycan biosynthetic process |
| GO:0051895 | 0.00694 | 18.27162 | 0 | 2 | 15 | negative regulation of focal adhesion assembly |
| GO:0030178 | 0.00713 | 3.73766 | 2 | 6 | 200 | negative regulation of Wnt signaling pathway |
| GO:0031532 | 0.00715 | 5.57749 | 1 | 4 | 90 | actin cytoskeleton reorganization |
| GO:0048144 | 0.00715 | 5.57749 | 1 | 4 | 90 | fibroblast proliferation |
| GO:0008360 | 0.00718 | 4.39421 | 1 | 5 | 142 | regulation of cell shape |
| GO:0043087 | 0.00720 | 2.63229 | 4 | 10 | 475 | regulation of GTPase activity |
| GO:0050778 | 0.00730 | 2.22649 | 7 | 14 | 792 | positive regulation of immune response |
| GO:0031529 | 0.00732 | 8.13920 | 0 | 3 | 47 | ruffle organization |
| GO:0048534 | 0.00742 | 2.15830 | 7 | 15 | 877 | hematopoietic or lymphoid organ development |
| GO:0030838 | 0.00743 | 5.51306 | 1 | 4 | 91 | positive regulation of actin filament polymerization |
| GO:0033273 | 0.00743 | 5.51306 | 1 | 4 | 91 | response to vitamin |
| GO:0002237 | 0.00746 | 2.99440 | 3 | 8 | 333 | response to molecule of bacterial origin |
| GO:0071310 | 0.00747 | 1.70255 | 21 | 32 | 2453 | cellular response to organic substance |
| GO:0042592 | 0.00752 | 1.83184 | 14 | 24 | 1683 | homeostatic process |
| GO:0035148 | 0.00760 | 4.33048 | 1 | 5 | 144 | tube formation |
| GO:0071346 | 0.00760 | 4.33048 | 1 | 5 | 144 | cellular response to interferon-gamma |
| GO:0006953 | 0.00776 | 7.95787 | 0 | 3 | 48 | acute-phase response |
| GO:0009409 | 0.00776 | 7.95787 | 0 | 3 | 48 | response to cold |
| GO:0030850 | 0.00776 | 7.95787 | 0 | 3 | 48 | prostate gland development |
| GO:0050865 | 0.00779 | 2.47210 | 5 | 11 | 557 | regulation of cell activation |
| GO:0043508 | 0.00789 | 16.96552 | 0 | 2 | 16 | negative regulation of JUN kinase activity |
| GO:0050655 | 0.00789 | 16.96552 | 0 | 2 | 16 | dermatan sulfate proteoglycan metabolic process |
| GO:1903392 | 0.00789 | 16.96552 | 0 | 2 | 16 | negative regulation of adherens junction organization |
| GO:2000811 | 0.00789 | 16.96552 | 0 | 2 | 16 | negative regulation of anoikis |
| GO:0051234 | 0.00789 | 1.53720 | 44 | 58 | 5189 | establishment of localization |
| GO:0043405 | 0.00799 | 2.95729 | 3 | 8 | 337 | regulation of MAP kinase activity |
| GO:0031346 | 0.00813 | 2.94816 | 3 | 8 | 338 | positive regulation of cell projection organization |
| GO:0060326 | 0.00815 | 3.22643 | 2 | 7 | 270 | cell chemotaxis |
| GO:0032870 | 0.00821 | 2.35046 | 5 | 12 | 640 | cellular response to hormone stimulus |
| GO:0030514 | 0.00822 | 7.78442 | 0 | 3 | 49 | negative regulation of BMP signaling pathway |
| GO:0072678 | 0.00822 | 7.78442 | 0 | 3 | 49 | T cell migration |
| GO:0098662 | 0.00823 | 2.26450 | 6 | 13 | 721 | inorganic cation transmembrane transport |
| GO:0045766 | 0.00827 | 4.23825 | 1 | 5 | 147 | positive regulation of angiogenesis |
| GO:0007548 | 0.00831 | 3.21402 | 2 | 7 | 271 | sex differentiation |
| GO:0001649 | 0.00838 | 3.60601 | 2 | 6 | 207 | osteoblast differentiation |
| GO:0043281 | 0.00838 | 3.60601 | 2 | 6 | 207 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0010189 | 0.00846 | Inf | 0 | 1 | 1 | vitamin E biosynthetic process |
| GO:0010477 | 0.00846 | Inf | 0 | 1 | 1 | response to sulfur dioxide |
| GO:0030421 | 0.00846 | Inf | 0 | 1 | 1 | defecation |
| GO:0032605 | 0.00846 | Inf | 0 | 1 | 1 | hepatocyte growth factor production |
| GO:0032646 | 0.00846 | Inf | 0 | 1 | 1 | regulation of hepatocyte growth factor production |
| GO:0032686 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte growth factor production |
| GO:0032712 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of interleukin-3 production |
| GO:0042404 | 0.00846 | Inf | 0 | 1 | 1 | thyroid hormone catabolic process |
| GO:0044345 | 0.00846 | Inf | 0 | 1 | 1 | stromal-epithelial cell signaling involved in prostate gland development |
| GO:0044795 | 0.00846 | Inf | 0 | 1 | 1 | trans-Golgi network to recycling endosome transport |
| GO:0048175 | 0.00846 | Inf | 0 | 1 | 1 | hepatocyte growth factor biosynthetic process |
| GO:0048176 | 0.00846 | Inf | 0 | 1 | 1 | regulation of hepatocyte growth factor biosynthetic process |
| GO:0048178 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte growth factor biosynthetic process |
| GO:0060739 | 0.00846 | Inf | 0 | 1 | 1 | mesenchymal-epithelial cell signaling involved in prostate gland development |
| GO:0061185 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of dermatome development |
| GO:0071449 | 0.00846 | Inf | 0 | 1 | 1 | cellular response to lipid hydroperoxide |
| GO:0071656 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of granulocyte colony-stimulating factor production |
| GO:0090246 | 0.00846 | Inf | 0 | 1 | 1 | convergent extension involved in somitogenesis |
| GO:0099551 | 0.00846 | Inf | 0 | 1 | 1 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission |
| GO:1901257 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of macrophage colony-stimulating factor production |
| GO:1903775 | 0.00846 | Inf | 0 | 1 | 1 | regulation of DNA double-strand break processing |
| GO:1990654 | 0.00846 | Inf | 0 | 1 | 1 | sebum secreting cell proliferation |
| GO:1990771 | 0.00846 | Inf | 0 | 1 | 1 | clathrin-dependent extracellular exosome endocytosis |
| GO:2000080 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
| GO:2000212 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of glutamate metabolic process |
| GO:2000230 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of pancreatic stellate cell proliferation |
| GO:2000527 | 0.00846 | Inf | 0 | 1 | 1 | regulation of myeloid dendritic cell chemotaxis |
| GO:2000529 | 0.00846 | Inf | 0 | 1 | 1 | positive regulation of myeloid dendritic cell chemotaxis |
| GO:2000539 | 0.00846 | Inf | 0 | 1 | 1 | regulation of protein geranylgeranylation |
| GO:2000541 | 0.00846 | Inf | 0 | 1 | 1 | positive regulation of protein geranylgeranylation |
| GO:2000548 | 0.00846 | Inf | 0 | 1 | 1 | negative regulation of dendritic cell dendrite assembly |
| GO:0016331 | 0.00850 | 4.20836 | 1 | 5 | 148 | morphogenesis of embryonic epithelium |
| GO:0048546 | 0.00869 | 7.61835 | 0 | 3 | 50 | digestive tract morphogenesis |
| GO:0033630 | 0.00889 | 15.83356 | 0 | 2 | 17 | positive regulation of cell adhesion mediated by integrin |
| GO:0071380 | 0.00889 | 15.83356 | 0 | 2 | 17 | cellular response to prostaglandin E stimulus |
| GO:1904948 | 0.00889 | 15.83356 | 0 | 2 | 17 | midbrain dopaminergic neuron differentiation |
| GO:2000026 | 0.00890 | 1.76437 | 16 | 26 | 1897 | regulation of multicellular organismal development |
| GO:0002253 | 0.00891 | 2.32357 | 5 | 12 | 647 | activation of immune response |
| GO:0051270 | 0.00894 | 2.10930 | 8 | 15 | 896 | regulation of cellular component movement |
| GO:2000021 | 0.00896 | 3.55236 | 2 | 6 | 210 | regulation of ion homeostasis |
| GO:0043550 | 0.00918 | 7.45920 | 0 | 3 | 51 | regulation of lipid kinase activity |
| GO:0098655 | 0.00926 | 2.15954 | 7 | 14 | 815 | cation transmembrane transport |
| GO:0008585 | 0.00927 | 5.15558 | 1 | 4 | 97 | female gonad development |
| GO:0045595 | 0.00940 | 1.79348 | 15 | 24 | 1715 | regulation of cell differentiation |
| GO:0003006 | 0.00943 | 2.30472 | 6 | 12 | 652 | developmental process involved in reproduction |
| GO:0038127 | 0.00948 | 4.09289 | 1 | 5 | 152 | ERBB signaling pathway |
| GO:0009887 | 0.00963 | 2.03897 | 8 | 16 | 990 | animal organ morphogenesis |
| GO:0098660 | 0.00964 | 2.14828 | 7 | 14 | 819 | inorganic ion transmembrane transport |
| GO:0097435 | 0.00987 | 2.38624 | 5 | 11 | 576 | supramolecular fiber organization |
| GO:1901700 | 0.00992 | 1.82875 | 13 | 22 | 1535 | response to oxygen-containing compound |
| GO:0044342 | 0.00995 | 14.84310 | 0 | 2 | 18 | type B pancreatic cell proliferation |
| GO:0031668 | 0.00999 | 3.46635 | 2 | 6 | 215 | cellular response to extracellular stimulus |
| GO:0050870 | 0.00999 | 3.46635 | 2 | 6 | 215 | positive regulation of T cell activation |
| GO:2001236 | 0.00999 | 4.03748 | 1 | 5 | 154 | regulation of extrinsic apoptotic signaling pathway |
| GO:0032103 | 0.01002 | 3.09489 | 2 | 7 | 281 | positive regulation of response to external stimulus |
| GO:0007015 | 0.01023 | 2.82583 | 3 | 8 | 352 | actin filament organization |
| GO:0002695 | 0.01026 | 4.01033 | 1 | 5 | 155 | negative regulation of leukocyte activation |
| GO:0052547 | 0.01037 | 2.63012 | 4 | 9 | 426 | regulation of peptidase activity |
| GO:0007204 | 0.01078 | 3.04964 | 2 | 7 | 285 | positive regulation of cytosolic calcium ion concentration |
| GO:0046545 | 0.01101 | 4.89111 | 1 | 4 | 102 | development of primary female sexual characteristics |
| GO:2000278 | 0.01101 | 4.89111 | 1 | 4 | 102 | regulation of DNA biosynthetic process |
| GO:0021915 | 0.01108 | 3.93100 | 1 | 5 | 158 | neural tube development |
| GO:0033627 | 0.01128 | 6.88381 | 0 | 3 | 55 | cell adhesion mediated by integrin |
| GO:0032526 | 0.01138 | 4.84142 | 1 | 4 | 103 | response to retinoic acid |
| GO:0030097 | 0.01140 | 2.10168 | 7 | 14 | 836 | hemopoiesis |
| GO:0007409 | 0.01145 | 2.58562 | 4 | 9 | 433 | axonogenesis |
| GO:0046903 | 0.01159 | 1.80002 | 13 | 22 | 1557 | secretion |
| GO:0051271 | 0.01177 | 2.99488 | 2 | 7 | 290 | negative regulation of cellular component movement |
| GO:0048812 | 0.01180 | 2.32244 | 5 | 11 | 591 | neuron projection morphogenesis |
| GO:0045453 | 0.01185 | 6.75354 | 0 | 3 | 56 | bone resorption |
| GO:0046530 | 0.01185 | 6.75354 | 0 | 3 | 56 | photoreceptor cell differentiation |
| GO:0002285 | 0.01195 | 3.85473 | 1 | 5 | 161 | lymphocyte activation involved in immune response |
| GO:0008064 | 0.01195 | 3.85473 | 1 | 5 | 161 | regulation of actin polymerization or depolymerization |
| GO:0030307 | 0.01195 | 3.85473 | 1 | 5 | 161 | positive regulation of cell growth |
| GO:0050954 | 0.01195 | 3.85473 | 1 | 5 | 161 | sensory perception of mechanical stimulus |
| GO:0032211 | 0.01222 | 13.19234 | 0 | 2 | 20 | negative regulation of telomere maintenance via telomerase |
| GO:0035357 | 0.01222 | 13.19234 | 0 | 2 | 20 | peroxisome proliferator activated receptor signaling pathway |
| GO:0035584 | 0.01222 | 13.19234 | 0 | 2 | 20 | calcium-mediated signaling using intracellular calcium source |
| GO:0060008 | 0.01222 | 13.19234 | 0 | 2 | 20 | Sertoli cell differentiation |
| GO:0071305 | 0.01222 | 13.19234 | 0 | 2 | 20 | cellular response to vitamin D |
| GO:1901889 | 0.01222 | 13.19234 | 0 | 2 | 20 | negative regulation of cell junction assembly |
| GO:2000050 | 0.01222 | 13.19234 | 0 | 2 | 20 | regulation of non-canonical Wnt signaling pathway |
| GO:0030832 | 0.01225 | 3.82995 | 1 | 5 | 162 | regulation of actin filament length |
| GO:0046661 | 0.01225 | 3.82995 | 1 | 5 | 162 | male sex differentiation |
| GO:0032879 | 0.01228 | 1.62341 | 22 | 33 | 2641 | regulation of localization |
| GO:0001541 | 0.01243 | 6.62809 | 0 | 3 | 57 | ovarian follicle development |
| GO:0010812 | 0.01243 | 6.62809 | 0 | 3 | 57 | negative regulation of cell-substrate adhesion |
| GO:0042698 | 0.01254 | 4.69820 | 1 | 4 | 106 | ovulation cycle |
| GO:0048589 | 0.01264 | 2.29783 | 5 | 11 | 597 | developmental growth |
| GO:0006464 | 0.01281 | 1.52458 | 35 | 47 | 4108 | cellular protein modification process |
| GO:0036211 | 0.01281 | 1.52458 | 35 | 47 | 4108 | protein modification process |
| GO:0030334 | 0.01291 | 2.12929 | 6 | 13 | 764 | regulation of cell migration |
| GO:0034341 | 0.01317 | 3.75748 | 1 | 5 | 165 | response to interferon-gamma |
| GO:0071222 | 0.01317 | 3.75748 | 1 | 5 | 165 | cellular response to lipopolysaccharide |
| GO:0002009 | 0.01321 | 2.38876 | 4 | 10 | 521 | morphogenesis of an epithelium |
| GO:0051348 | 0.01331 | 2.69005 | 3 | 8 | 369 | negative regulation of transferase activity |
| GO:0031290 | 0.01343 | 12.49728 | 0 | 2 | 21 | retinal ganglion cell axon guidance |
| GO:0032958 | 0.01343 | 12.49728 | 0 | 2 | 21 | inositol phosphate biosynthetic process |
| GO:0071498 | 0.01343 | 12.49728 | 0 | 2 | 21 | cellular response to fluid shear stress |
| GO:1901623 | 0.01343 | 12.49728 | 0 | 2 | 21 | regulation of lymphocyte chemotaxis |
| GO:0048771 | 0.01349 | 3.73393 | 1 | 5 | 166 | tissue remodeling |
| GO:0051239 | 0.01361 | 1.59122 | 24 | 35 | 2864 | regulation of multicellular organismal process |
| GO:1902041 | 0.01364 | 6.39062 | 0 | 3 | 59 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0120039 | 0.01384 | 2.26580 | 5 | 11 | 605 | plasma membrane bounded cell projection morphogenesis |
| GO:0051049 | 0.01385 | 1.70921 | 16 | 25 | 1870 | regulation of transport |
| GO:0043066 | 0.01404 | 2.04415 | 7 | 14 | 858 | negative regulation of apoptotic process |
| GO:0031334 | 0.01412 | 3.20241 | 2 | 6 | 232 | positive regulation of protein complex assembly |
| GO:0090090 | 0.01415 | 3.68768 | 1 | 5 | 168 | negative regulation of canonical Wnt signaling pathway |
| GO:1904018 | 0.01415 | 3.68768 | 1 | 5 | 168 | positive regulation of vasculature development |
| GO:0060071 | 0.01421 | 4.51986 | 1 | 4 | 110 | Wnt signaling pathway, planar cell polarity pathway |
| GO:0090101 | 0.01421 | 4.51986 | 1 | 4 | 110 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0048858 | 0.01431 | 2.25400 | 5 | 11 | 608 | cell projection morphogenesis |
| GO:0051235 | 0.01444 | 2.87102 | 3 | 7 | 302 | maintenance of location |
| GO:0060070 | 0.01444 | 2.87102 | 3 | 7 | 302 | canonical Wnt signaling pathway |
| GO:0046777 | 0.01468 | 3.17395 | 2 | 6 | 234 | protein autophosphorylation |
| GO:0002335 | 0.01469 | 11.87172 | 0 | 2 | 22 | mature B cell differentiation |
| GO:0002438 | 0.01469 | 11.87172 | 0 | 2 | 22 | acute inflammatory response to antigenic stimulus |
| GO:0002825 | 0.01469 | 11.87172 | 0 | 2 | 22 | regulation of T-helper 1 type immune response |
| GO:0048667 | 0.01508 | 2.33689 | 4 | 10 | 532 | cell morphogenesis involved in neuron differentiation |
| GO:0051209 | 0.01509 | 4.43564 | 1 | 4 | 112 | release of sequestered calcium ion into cytosol |
| GO:0051283 | 0.01509 | 4.43564 | 1 | 4 | 112 | negative regulation of sequestering of calcium ion |
| GO:0090175 | 0.01509 | 4.43564 | 1 | 4 | 112 | regulation of establishment of planar polarity |
| GO:2000116 | 0.01525 | 3.14598 | 2 | 6 | 236 | regulation of cysteine-type endopeptidase activity |
| GO:0050707 | 0.01552 | 3.59851 | 1 | 5 | 172 | regulation of cytokine secretion |
| GO:0051282 | 0.01554 | 4.39469 | 1 | 4 | 113 | regulation of sequestering of calcium ion |
| GO:0045859 | 0.01585 | 2.06873 | 7 | 13 | 785 | regulation of protein kinase activity |
| GO:0010952 | 0.01587 | 3.57688 | 1 | 5 | 173 | positive regulation of peptidase activity |
| GO:0071219 | 0.01587 | 3.57688 | 1 | 5 | 173 | cellular response to molecule of bacterial origin |
| GO:0043069 | 0.01595 | 2.00908 | 7 | 14 | 872 | negative regulation of programmed cell death |
| GO:0050767 | 0.01597 | 2.13449 | 6 | 12 | 701 | regulation of neurogenesis |
| GO:0021952 | 0.01600 | 11.30575 | 0 | 2 | 23 | central nervous system projection neuron axonogenesis |
| GO:2000209 | 0.01600 | 11.30575 | 0 | 2 | 23 | regulation of anoikis |
| GO:0032268 | 0.01620 | 1.58531 | 23 | 33 | 2694 | regulation of cellular protein metabolic process |
| GO:0050731 | 0.01623 | 3.55550 | 1 | 5 | 174 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0050866 | 0.01623 | 3.55550 | 1 | 5 | 174 | negative regulation of cell activation |
| GO:0002548 | 0.01626 | 5.96319 | 1 | 3 | 63 | monocyte chemotaxis |
| GO:0015909 | 0.01626 | 5.96319 | 1 | 3 | 63 | long-chain fatty acid transport |
| GO:0032273 | 0.01648 | 4.31500 | 1 | 4 | 115 | positive regulation of protein polymerization |
| GO:0051960 | 0.01677 | 2.05203 | 7 | 13 | 791 | regulation of nervous system development |
| GO:0001798 | 0.01684 | 118.03425 | 0 | 1 | 2 | positive regulation of type IIa hypersensitivity |
| GO:0002086 | 0.01684 | 118.03425 | 0 | 1 | 2 | diaphragm contraction |
| GO:0002337 | 0.01684 | 118.03425 | 0 | 1 | 2 | B-1a B cell differentiation |
| GO:0002519 | 0.01684 | 118.03425 | 0 | 1 | 2 | natural killer cell tolerance induction |
| GO:0002652 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of tolerance induction dependent upon immune response |
| GO:0002835 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of response to tumor cell |
| GO:0002838 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of immune response to tumor cell |
| GO:0002856 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of natural killer cell mediated immune response to tumor cell |
| GO:0002859 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0002894 | 0.01684 | 118.03425 | 0 | 1 | 2 | positive regulation of type II hypersensitivity |
| GO:0003366 | 0.01684 | 118.03425 | 0 | 1 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
| GO:0009082 | 0.01684 | 118.03425 | 0 | 1 | 2 | branched-chain amino acid biosynthetic process |
| GO:0009098 | 0.01684 | 118.03425 | 0 | 1 | 2 | leucine biosynthetic process |
| GO:0009099 | 0.01684 | 118.03425 | 0 | 1 | 2 | valine biosynthetic process |
| GO:0009257 | 0.01684 | 118.03425 | 0 | 1 | 2 | 10-formyltetrahydrofolate biosynthetic process |
| GO:0010752 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of cGMP-mediated signaling |
| GO:0014839 | 0.01684 | 118.03425 | 0 | 1 | 2 | myoblast migration involved in skeletal muscle regeneration |
| GO:0021823 | 0.01684 | 118.03425 | 0 | 1 | 2 | cerebral cortex tangential migration using cell-cell interactions |
| GO:0021827 | 0.01684 | 118.03425 | 0 | 1 | 2 | postnatal olfactory bulb interneuron migration |
| GO:0021836 | 0.01684 | 118.03425 | 0 | 1 | 2 | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
| GO:0022601 | 0.01684 | 118.03425 | 0 | 1 | 2 | menstrual cycle phase |
| GO:0032972 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of muscle filament sliding speed |
| GO:0033082 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of extrathymic T cell differentiation |
| GO:0035544 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of SNARE complex assembly |
| GO:0035759 | 0.01684 | 118.03425 | 0 | 1 | 2 | mesangial cell-matrix adhesion |
| GO:0036292 | 0.01684 | 118.03425 | 0 | 1 | 2 | DNA rewinding |
| GO:0044343 | 0.01684 | 118.03425 | 0 | 1 | 2 | canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation |
| GO:0048250 | 0.01684 | 118.03425 | 0 | 1 | 2 | mitochondrial iron ion transport |
| GO:0050925 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of negative chemotaxis |
| GO:0060279 | 0.01684 | 118.03425 | 0 | 1 | 2 | positive regulation of ovulation |
| GO:0060694 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of cholesterol transporter activity |
| GO:0071306 | 0.01684 | 118.03425 | 0 | 1 | 2 | cellular response to vitamin E |
| GO:0072343 | 0.01684 | 118.03425 | 0 | 1 | 2 | pancreatic stellate cell proliferation |
| GO:0086098 | 0.01684 | 118.03425 | 0 | 1 | 2 | angiotensin-activated signaling pathway involved in heart process |
| GO:0099538 | 0.01684 | 118.03425 | 0 | 1 | 2 | synaptic signaling via neuropeptide |
| GO:0099540 | 0.01684 | 118.03425 | 0 | 1 | 2 | trans-synaptic signaling by neuropeptide |
| GO:1901558 | 0.01684 | 118.03425 | 0 | 1 | 2 | response to metformin |
| GO:1901740 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of myoblast fusion |
| GO:1904806 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of protein oxidation |
| GO:1904808 | 0.01684 | 118.03425 | 0 | 1 | 2 | positive regulation of protein oxidation |
| GO:2000054 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:2000079 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
| GO:2000211 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of glutamate metabolic process |
| GO:2000229 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of pancreatic stellate cell proliferation |
| GO:2000296 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of hydrogen peroxide catabolic process |
| GO:2000324 | 0.01684 | 118.03425 | 0 | 1 | 2 | positive regulation of glucocorticoid receptor signaling pathway |
| GO:2000386 | 0.01684 | 118.03425 | 0 | 1 | 2 | positive regulation of ovarian follicle development |
| GO:2000521 | 0.01684 | 118.03425 | 0 | 1 | 2 | negative regulation of immunological synapse formation |
| GO:2000537 | 0.01684 | 118.03425 | 0 | 1 | 2 | regulation of B cell chemotaxis |
| GO:2000538 | 0.01684 | 118.03425 | 0 | 1 | 2 | positive regulation of B cell chemotaxis |
| GO:0050790 | 0.01689 | 1.62091 | 19 | 29 | 2298 | regulation of catalytic activity |
| GO:0051208 | 0.01695 | 4.27622 | 1 | 4 | 116 | sequestering of calcium ion |
| GO:0032940 | 0.01718 | 1.77283 | 12 | 20 | 1426 | secretion by cell |
| GO:0051894 | 0.01736 | 10.79122 | 0 | 2 | 24 | positive regulation of focal adhesion assembly |
| GO:0060330 | 0.01736 | 10.79122 | 0 | 2 | 24 | regulation of response to interferon-gamma |
| GO:0060334 | 0.01736 | 10.79122 | 0 | 2 | 24 | regulation of interferon-gamma-mediated signaling pathway |
| GO:0046660 | 0.01744 | 4.23813 | 1 | 4 | 117 | female sex differentiation |
| GO:0060627 | 0.01747 | 2.39960 | 4 | 9 | 465 | regulation of vesicle-mediated transport |
| GO:0006508 | 0.01748 | 1.68665 | 15 | 24 | 1811 | proteolysis |
| GO:0032990 | 0.01759 | 2.18199 | 5 | 11 | 627 | cell part morphogenesis |
| GO:0048729 | 0.01759 | 2.18199 | 5 | 11 | 627 | tissue morphogenesis |
| GO:0006909 | 0.01779 | 2.74773 | 3 | 7 | 315 | phagocytosis |
| GO:0001655 | 0.01806 | 2.73867 | 3 | 7 | 316 | urogenital system development |
| GO:0097529 | 0.01812 | 3.45232 | 2 | 5 | 179 | myeloid leukocyte migration |
| GO:0001558 | 0.01822 | 2.53222 | 3 | 8 | 391 | regulation of cell growth |
| GO:0065008 | 0.01833 | 1.51235 | 30 | 41 | 3551 | regulation of biological quality |
| GO:0043086 | 0.01838 | 1.97037 | 8 | 14 | 888 | negative regulation of catalytic activity |
| GO:0051965 | 0.01840 | 5.67824 | 1 | 3 | 66 | positive regulation of synapse assembly |
| GO:0060291 | 0.01840 | 5.67824 | 1 | 3 | 66 | long-term synaptic potentiation |
| GO:1903725 | 0.01840 | 5.67824 | 1 | 3 | 66 | regulation of phospholipid metabolic process |
| GO:0003231 | 0.01844 | 4.16394 | 1 | 4 | 119 | cardiac ventricle development |
| GO:0045807 | 0.01844 | 4.16394 | 1 | 4 | 119 | positive regulation of endocytosis |
| GO:0043254 | 0.01847 | 2.52548 | 3 | 8 | 392 | regulation of protein complex assembly |
| GO:1905330 | 0.01852 | 3.43239 | 2 | 5 | 180 | regulation of morphogenesis of an epithelium |
| GO:0051480 | 0.01863 | 2.72074 | 3 | 7 | 318 | regulation of cytosolic calcium ion concentration |
| GO:0035902 | 0.01877 | 10.32144 | 0 | 2 | 25 | response to immobilization stress |
| GO:0032868 | 0.01899 | 2.98787 | 2 | 6 | 248 | response to insulin |
| GO:0060828 | 0.01899 | 2.98787 | 2 | 6 | 248 | regulation of canonical Wnt signaling pathway |
| GO:0043647 | 0.01915 | 5.58919 | 1 | 3 | 67 | inositol phosphate metabolic process |
| GO:0032844 | 0.01928 | 2.35710 | 4 | 9 | 473 | regulation of homeostatic process |
| GO:1902905 | 0.01933 | 3.39321 | 2 | 5 | 182 | positive regulation of supramolecular fiber organization |
| GO:0032271 | 0.01974 | 3.37395 | 2 | 5 | 183 | regulation of protein polymerization |
| GO:0050863 | 0.01980 | 2.68556 | 3 | 7 | 322 | regulation of T cell activation |
| GO:0050764 | 0.01991 | 5.50288 | 1 | 3 | 68 | regulation of phagocytosis |
| GO:0001736 | 0.02001 | 4.05737 | 1 | 4 | 122 | establishment of planar polarity |
| GO:0007164 | 0.02001 | 4.05737 | 1 | 4 | 122 | establishment of tissue polarity |
| GO:0051240 | 0.02005 | 1.71930 | 13 | 21 | 1544 | positive regulation of multicellular organismal process |
| GO:0043542 | 0.02016 | 3.35491 | 2 | 5 | 184 | endothelial cell migration |
| GO:0045577 | 0.02022 | 9.89080 | 0 | 2 | 26 | regulation of B cell differentiation |
| GO:0060740 | 0.02022 | 9.89080 | 0 | 2 | 26 | prostate gland epithelium morphogenesis |
| GO:1900027 | 0.02022 | 9.89080 | 0 | 2 | 26 | regulation of ruffle assembly |
| GO:1903393 | 0.02022 | 9.89080 | 0 | 2 | 26 | positive regulation of adherens junction organization |
| GO:0052548 | 0.02030 | 2.47924 | 3 | 8 | 399 | regulation of endopeptidase activity |
| GO:0010033 | 0.02047 | 1.52954 | 26 | 36 | 3051 | response to organic substance |
| GO:0010675 | 0.02055 | 4.02304 | 1 | 4 | 123 | regulation of cellular carbohydrate metabolic process |
| GO:0008154 | 0.02058 | 3.33607 | 2 | 5 | 185 | actin polymerization or depolymerization |
| GO:0030111 | 0.02071 | 2.65975 | 3 | 7 | 325 | regulation of Wnt signaling pathway |
| GO:0090287 | 0.02072 | 2.92652 | 2 | 6 | 253 | regulation of cellular response to growth factor stimulus |
| GO:0031099 | 0.02101 | 3.31745 | 2 | 5 | 186 | regeneration |
| GO:0031669 | 0.02101 | 3.31745 | 2 | 5 | 186 | cellular response to nutrient levels |
| GO:0034220 | 0.02109 | 1.84876 | 9 | 16 | 1084 | ion transmembrane transport |
| GO:0002822 | 0.02110 | 3.98928 | 1 | 4 | 124 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0009628 | 0.02130 | 1.81206 | 10 | 17 | 1177 | response to abiotic stimulus |
| GO:2000145 | 0.02146 | 1.97995 | 7 | 13 | 818 | regulation of cell motility |
| GO:0031338 | 0.02148 | 5.33800 | 1 | 3 | 70 | regulation of vesicle fusion |
| GO:0032814 | 0.02172 | 9.49462 | 0 | 2 | 27 | regulation of natural killer cell activation |
| GO:0060292 | 0.02172 | 9.49462 | 0 | 2 | 27 | long term synaptic depression |
| GO:1904357 | 0.02172 | 9.49462 | 0 | 2 | 27 | negative regulation of telomere maintenance via telomere lengthening |
| GO:0010604 | 0.02194 | 1.52036 | 26 | 36 | 3066 | positive regulation of macromolecule metabolic process |
| GO:0045927 | 0.02218 | 2.87921 | 2 | 6 | 257 | positive regulation of growth |
| GO:0090263 | 0.02223 | 3.92342 | 1 | 4 | 126 | positive regulation of canonical Wnt signaling pathway |
| GO:0051130 | 0.02241 | 1.80040 | 10 | 17 | 1184 | positive regulation of cellular component organization |
| GO:0040008 | 0.02250 | 2.09713 | 6 | 11 | 651 | regulation of growth |
| GO:0016049 | 0.02251 | 2.29109 | 4 | 9 | 486 | cell growth |
| GO:0050680 | 0.02281 | 3.89130 | 1 | 4 | 127 | negative regulation of epithelial cell proliferation |
| GO:0030336 | 0.02293 | 2.85611 | 2 | 6 | 259 | negative regulation of cell migration |
| GO:0071383 | 0.02293 | 2.85611 | 2 | 6 | 259 | cellular response to steroid hormone stimulus |
| GO:0050805 | 0.02312 | 5.18267 | 1 | 3 | 72 | negative regulation of synaptic transmission |
| GO:0060284 | 0.02322 | 1.95698 | 7 | 13 | 827 | regulation of cell development |
| GO:0034367 | 0.02326 | 9.12891 | 0 | 2 | 28 | macromolecular complex remodeling |
| GO:0034368 | 0.02326 | 9.12891 | 0 | 2 | 28 | protein-lipid complex remodeling |
| GO:0034369 | 0.02326 | 9.12891 | 0 | 2 | 28 | plasma lipoprotein particle remodeling |
| GO:0045880 | 0.02326 | 9.12891 | 0 | 2 | 28 | positive regulation of smoothened signaling pathway |
| GO:0060512 | 0.02326 | 9.12891 | 0 | 2 | 28 | prostate gland morphogenesis |
| GO:0010631 | 0.02331 | 2.84470 | 2 | 6 | 260 | epithelial cell migration |
| GO:0050807 | 0.02339 | 3.85969 | 1 | 4 | 128 | regulation of synapse organization |
| GO:0097553 | 0.02339 | 3.85969 | 1 | 4 | 128 | calcium ion transmembrane import into cytosol |
| GO:0019221 | 0.02364 | 2.08024 | 6 | 11 | 656 | cytokine-mediated signaling pathway |
| GO:0051338 | 0.02366 | 1.85858 | 9 | 15 | 1008 | regulation of transferase activity |
| GO:0070887 | 0.02385 | 1.51624 | 25 | 35 | 2980 | cellular response to chemical stimulus |
| GO:0032652 | 0.02397 | 5.10833 | 1 | 3 | 73 | regulation of interleukin-1 production |
| GO:0002683 | 0.02402 | 2.39761 | 3 | 8 | 412 | negative regulation of immune system process |
| GO:0009611 | 0.02410 | 2.07356 | 6 | 11 | 658 | response to wounding |
| GO:0045664 | 0.02412 | 2.15743 | 5 | 10 | 574 | regulation of neuron differentiation |
| GO:0001763 | 0.02418 | 3.19261 | 2 | 5 | 193 | morphogenesis of a branching structure |
| GO:0090132 | 0.02449 | 2.81099 | 2 | 6 | 263 | epithelium migration |
| GO:0007173 | 0.02459 | 3.79798 | 1 | 4 | 130 | epidermal growth factor receptor signaling pathway |
| GO:0048565 | 0.02459 | 3.79798 | 1 | 4 | 130 | digestive tract development |
| GO:0043412 | 0.02479 | 1.44625 | 37 | 48 | 4375 | macromolecule modification |
| GO:0002675 | 0.02484 | 8.79029 | 0 | 2 | 29 | positive regulation of acute inflammatory response |
| GO:0010719 | 0.02484 | 8.79029 | 0 | 2 | 29 | negative regulation of epithelial to mesenchymal transition |
| GO:0010743 | 0.02484 | 8.79029 | 0 | 2 | 29 | regulation of macrophage derived foam cell differentiation |
| GO:0021955 | 0.02484 | 8.79029 | 0 | 2 | 29 | central nervous system neuron axonogenesis |
| GO:0030866 | 0.02484 | 8.79029 | 0 | 2 | 29 | cortical actin cytoskeleton organization |
| GO:0034698 | 0.02484 | 8.79029 | 0 | 2 | 29 | response to gonadotropin |
| GO:0050482 | 0.02484 | 8.79029 | 0 | 2 | 29 | arachidonic acid secretion |
| GO:1903963 | 0.02484 | 8.79029 | 0 | 2 | 29 | arachidonate transport |
| GO:0032869 | 0.02513 | 3.15864 | 2 | 5 | 195 | cellular response to insulin stimulus |
| GO:0071216 | 0.02513 | 3.15864 | 2 | 5 | 195 | cellular response to biotic stimulus |
| GO:0001545 | 0.02516 | 59.01370 | 0 | 1 | 3 | primary ovarian follicle growth |
| GO:0001794 | 0.02516 | 59.01370 | 0 | 1 | 3 | type IIa hypersensitivity |
| GO:0001796 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of type IIa hypersensitivity |
| GO:0001923 | 0.02516 | 59.01370 | 0 | 1 | 3 | B-1 B cell differentiation |
| GO:0002445 | 0.02516 | 59.01370 | 0 | 1 | 3 | type II hypersensitivity |
| GO:0002461 | 0.02516 | 59.01370 | 0 | 1 | 3 | tolerance induction dependent upon immune response |
| GO:0002892 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of type II hypersensitivity |
| GO:0003011 | 0.02516 | 59.01370 | 0 | 1 | 3 | involuntary skeletal muscle contraction |
| GO:0006982 | 0.02516 | 59.01370 | 0 | 1 | 3 | response to lipid hydroperoxide |
| GO:0014707 | 0.02516 | 59.01370 | 0 | 1 | 3 | branchiomeric skeletal muscle development |
| GO:0030886 | 0.02516 | 59.01370 | 0 | 1 | 3 | negative regulation of myeloid dendritic cell activation |
| GO:0032672 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of interleukin-3 production |
| GO:0033078 | 0.02516 | 59.01370 | 0 | 1 | 3 | extrathymic T cell differentiation |
| GO:0034242 | 0.02516 | 59.01370 | 0 | 1 | 3 | negative regulation of syncytium formation by plasma membrane fusion |
| GO:0043163 | 0.02516 | 59.01370 | 0 | 1 | 3 | cell envelope organization |
| GO:0045229 | 0.02516 | 59.01370 | 0 | 1 | 3 | external encapsulating structure organization |
| GO:0045763 | 0.02516 | 59.01370 | 0 | 1 | 3 | negative regulation of cellular amino acid metabolic process |
| GO:0046005 | 0.02516 | 59.01370 | 0 | 1 | 3 | positive regulation of circadian sleep/wake cycle, REM sleep |
| GO:0046882 | 0.02516 | 59.01370 | 0 | 1 | 3 | negative regulation of follicle-stimulating hormone secretion |
| GO:0050904 | 0.02516 | 59.01370 | 0 | 1 | 3 | diapedesis |
| GO:0050955 | 0.02516 | 59.01370 | 0 | 1 | 3 | thermoception |
| GO:0050968 | 0.02516 | 59.01370 | 0 | 1 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:0060278 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of ovulation |
| GO:0060447 | 0.02516 | 59.01370 | 0 | 1 | 3 | bud outgrowth involved in lung branching |
| GO:0071393 | 0.02516 | 59.01370 | 0 | 1 | 3 | cellular response to progesterone stimulus |
| GO:0071655 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of granulocyte colony-stimulating factor production |
| GO:0072092 | 0.02516 | 59.01370 | 0 | 1 | 3 | ureteric bud invasion |
| GO:1900138 | 0.02516 | 59.01370 | 0 | 1 | 3 | negative regulation of phospholipase A2 activity |
| GO:1902463 | 0.02516 | 59.01370 | 0 | 1 | 3 | protein localization to cell leading edge |
| GO:1903238 | 0.02516 | 59.01370 | 0 | 1 | 3 | positive regulation of leukocyte tethering or rolling |
| GO:2000053 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:2000196 | 0.02516 | 59.01370 | 0 | 1 | 3 | positive regulation of female gonad development |
| GO:2000295 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of hydrogen peroxide catabolic process |
| GO:2000520 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of immunological synapse formation |
| GO:2000547 | 0.02516 | 59.01370 | 0 | 1 | 3 | regulation of dendritic cell dendrite assembly |
| GO:2001189 | 0.02516 | 59.01370 | 0 | 1 | 3 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:2001226 | 0.02516 | 59.01370 | 0 | 1 | 3 | negative regulation of chloride transport |
| GO:0010942 | 0.02530 | 2.05704 | 6 | 11 | 663 | positive regulation of cell death |
| GO:0009893 | 0.02534 | 1.48874 | 28 | 38 | 3308 | positive regulation of metabolic process |
| GO:0000904 | 0.02554 | 2.05377 | 6 | 11 | 664 | cell morphogenesis involved in differentiation |
| GO:0033043 | 0.02565 | 1.76946 | 10 | 17 | 1203 | regulation of organelle organization |
| GO:0033143 | 0.02571 | 4.96586 | 1 | 3 | 75 | regulation of intracellular steroid hormone receptor signaling pathway |
| GO:0006812 | 0.02580 | 1.80016 | 9 | 16 | 1111 | cation transport |
| GO:0045471 | 0.02582 | 3.73820 | 1 | 4 | 132 | response to ethanol |
| GO:0051017 | 0.02582 | 3.73820 | 1 | 4 | 132 | actin filament bundle assembly |
| GO:0050663 | 0.02612 | 3.12537 | 2 | 5 | 197 | cytokine secretion |
| GO:0051051 | 0.02641 | 2.22390 | 4 | 9 | 500 | negative regulation of transport |
| GO:0050803 | 0.02646 | 3.70900 | 1 | 4 | 133 | regulation of synapse structure or activity |
| GO:0051250 | 0.02646 | 3.70900 | 1 | 4 | 133 | negative regulation of lymphocyte activation |
| GO:0045920 | 0.02647 | 8.47586 | 0 | 2 | 30 | negative regulation of exocytosis |
| GO:0043407 | 0.02660 | 4.89755 | 1 | 3 | 76 | negative regulation of MAP kinase activity |
| GO:0050772 | 0.02660 | 4.89755 | 1 | 3 | 76 | positive regulation of axonogenesis |
| GO:0065007 | 0.02675 | 1.47320 | 102 | 113 | 12054 | biological regulation |
| GO:0006898 | 0.02678 | 2.51458 | 3 | 7 | 343 | receptor-mediated endocytosis |
| GO:0043549 | 0.02684 | 1.91496 | 7 | 13 | 844 | regulation of kinase activity |
| GO:0050708 | 0.02686 | 2.34410 | 4 | 8 | 421 | regulation of protein secretion |
| GO:0090130 | 0.02696 | 2.74589 | 2 | 6 | 269 | tissue migration |
| GO:0002819 | 0.02775 | 3.65195 | 1 | 4 | 135 | regulation of adaptive immune response |
| GO:0022607 | 0.02811 | 1.50829 | 24 | 33 | 2808 | cellular component assembly |
| GO:1905114 | 0.02814 | 2.09964 | 5 | 10 | 589 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0050869 | 0.02815 | 8.18312 | 0 | 2 | 31 | negative regulation of B cell activation |
| GO:1901890 | 0.02815 | 8.18312 | 0 | 2 | 31 | positive regulation of cell junction assembly |
| GO:0050671 | 0.02841 | 3.62407 | 1 | 4 | 136 | positive regulation of lymphocyte proliferation |
| GO:0061572 | 0.02841 | 3.62407 | 1 | 4 | 136 | actin filament bundle organization |
| GO:0010035 | 0.02884 | 2.18720 | 4 | 9 | 508 | response to inorganic substance |
| GO:0032946 | 0.02907 | 3.59661 | 1 | 4 | 137 | positive regulation of mononuclear cell proliferation |
| GO:0043524 | 0.02907 | 3.59661 | 1 | 4 | 137 | negative regulation of neuron apoptotic process |
| GO:2000146 | 0.02914 | 2.69387 | 2 | 6 | 274 | negative regulation of cell motility |
| GO:0030595 | 0.02921 | 3.02959 | 2 | 5 | 203 | leukocyte chemotaxis |
| GO:0002824 | 0.02939 | 4.70340 | 1 | 3 | 79 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0046427 | 0.02939 | 4.70340 | 1 | 3 | 79 | positive regulation of JAK-STAT cascade |
| GO:1904894 | 0.02939 | 4.70340 | 1 | 3 | 79 | positive regulation of STAT cascade |
| GO:0001738 | 0.02975 | 3.56956 | 1 | 4 | 138 | morphogenesis of a polarized epithelium |
| GO:0008038 | 0.02986 | 7.90989 | 0 | 2 | 32 | neuron recognition |
| GO:0045923 | 0.02986 | 7.90989 | 0 | 2 | 32 | positive regulation of fatty acid metabolic process |
| GO:0051495 | 0.03029 | 2.99894 | 2 | 5 | 205 | positive regulation of cytoskeleton organization |
| GO:0090288 | 0.03044 | 3.54292 | 1 | 4 | 139 | negative regulation of cellular response to growth factor stimulus |
| GO:0001667 | 0.03064 | 2.44046 | 3 | 7 | 353 | ameboidal-type cell migration |
| GO:0050670 | 0.03084 | 2.98385 | 2 | 5 | 206 | regulation of lymphocyte proliferation |
| GO:0032944 | 0.03140 | 2.96890 | 2 | 5 | 207 | regulation of mononuclear cell proliferation |
| GO:0071356 | 0.03144 | 2.64375 | 2 | 6 | 279 | cellular response to tumor necrosis factor |
| GO:0060548 | 0.03145 | 1.82464 | 8 | 14 | 954 | negative regulation of cell death |
| GO:0001881 | 0.03161 | 7.65428 | 0 | 2 | 33 | receptor recycling |
| GO:0043276 | 0.03161 | 7.65428 | 0 | 2 | 33 | anoikis |
| GO:0045907 | 0.03161 | 7.65428 | 0 | 2 | 33 | positive regulation of vasoconstriction |
| GO:0048147 | 0.03161 | 7.65428 | 0 | 2 | 33 | negative regulation of fibroblast proliferation |
| GO:0048246 | 0.03161 | 7.65428 | 0 | 2 | 33 | macrophage chemotaxis |
| GO:0008015 | 0.03176 | 2.14730 | 4 | 9 | 517 | blood circulation |
| GO:0043271 | 0.03184 | 3.49079 | 1 | 4 | 141 | negative regulation of ion transport |
| GO:0006911 | 0.03232 | 4.52400 | 1 | 3 | 82 | phagocytosis, engulfment |
| GO:0006919 | 0.03232 | 4.52400 | 1 | 3 | 82 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0009314 | 0.03249 | 2.25453 | 4 | 8 | 437 | response to radiation |
| GO:0030833 | 0.03255 | 3.46529 | 1 | 4 | 142 | regulation of actin filament polymerization |
| GO:1903169 | 0.03255 | 3.46529 | 1 | 4 | 142 | regulation of calcium ion transmembrane transport |
| GO:0032102 | 0.03287 | 2.61455 | 2 | 6 | 282 | negative regulation of response to external stimulus |
| GO:0007268 | 0.03294 | 2.04122 | 5 | 10 | 605 | chemical synaptic transmission |
| GO:0098916 | 0.03294 | 2.04122 | 5 | 10 | 605 | anterograde trans-synaptic signaling |
| GO:0051048 | 0.03310 | 2.92494 | 2 | 5 | 210 | negative regulation of secretion |
| GO:0055123 | 0.03328 | 3.44016 | 1 | 4 | 143 | digestive system development |
| GO:0002821 | 0.03333 | 4.46719 | 1 | 3 | 83 | positive regulation of adaptive immune response |
| GO:0008625 | 0.03333 | 4.46719 | 1 | 3 | 83 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0032612 | 0.03333 | 4.46719 | 1 | 3 | 83 | interleukin-1 production |
| GO:0048477 | 0.03333 | 4.46719 | 1 | 3 | 83 | oogenesis |
| GO:0071674 | 0.03333 | 4.46719 | 1 | 3 | 83 | mononuclear cell migration |
| GO:0001953 | 0.03340 | 7.41466 | 0 | 2 | 34 | negative regulation of cell-matrix adhesion |
| GO:0002714 | 0.03340 | 7.41466 | 0 | 2 | 34 | positive regulation of B cell mediated immunity |
| GO:0002891 | 0.03340 | 7.41466 | 0 | 2 | 34 | positive regulation of immunoglobulin mediated immune response |
| GO:0006692 | 0.03340 | 7.41466 | 0 | 2 | 34 | prostanoid metabolic process |
| GO:0006693 | 0.03340 | 7.41466 | 0 | 2 | 34 | prostaglandin metabolic process |
| GO:0010737 | 0.03340 | 7.41466 | 0 | 2 | 34 | protein kinase A signaling |
| GO:0030865 | 0.03340 | 7.41466 | 0 | 2 | 34 | cortical cytoskeleton organization |
| GO:0038179 | 0.03340 | 7.41466 | 0 | 2 | 34 | neurotrophin signaling pathway |
| GO:0097178 | 0.03340 | 7.41466 | 0 | 2 | 34 | ruffle assembly |
| GO:0002175 | 0.03341 | 39.34018 | 0 | 1 | 4 | protein localization to paranode region of axon |
| GO:0002408 | 0.03341 | 39.34018 | 0 | 1 | 4 | myeloid dendritic cell chemotaxis |
| GO:0006015 | 0.03341 | 39.34018 | 0 | 1 | 4 | 5-phosphoribose 1-diphosphate biosynthetic process |
| GO:0014034 | 0.03341 | 39.34018 | 0 | 1 | 4 | neural crest cell fate commitment |
| GO:0021825 | 0.03341 | 39.34018 | 0 | 1 | 4 | substrate-dependent cerebral cortex tangential migration |
| GO:0031394 | 0.03341 | 39.34018 | 0 | 1 | 4 | positive regulation of prostaglandin biosynthetic process |
| GO:0032632 | 0.03341 | 39.34018 | 0 | 1 | 4 | interleukin-3 production |
| GO:0032971 | 0.03341 | 39.34018 | 0 | 1 | 4 | regulation of muscle filament sliding |
| GO:0033031 | 0.03341 | 39.34018 | 0 | 1 | 4 | positive regulation of neutrophil apoptotic process |
| GO:0033600 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of mammary gland epithelial cell proliferation |
| GO:0036301 | 0.03341 | 39.34018 | 0 | 1 | 4 | macrophage colony-stimulating factor production |
| GO:0038165 | 0.03341 | 39.34018 | 0 | 1 | 4 | oncostatin-M-mediated signaling pathway |
| GO:0042360 | 0.03341 | 39.34018 | 0 | 1 | 4 | vitamin E metabolic process |
| GO:0042662 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0045578 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of B cell differentiation |
| GO:0045629 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of T-helper 2 cell differentiation |
| GO:0046391 | 0.03341 | 39.34018 | 0 | 1 | 4 | 5-phosphoribose 1-diphosphate metabolic process |
| GO:0048295 | 0.03341 | 39.34018 | 0 | 1 | 4 | positive regulation of isotype switching to IgE isotypes |
| GO:0050923 | 0.03341 | 39.34018 | 0 | 1 | 4 | regulation of negative chemotaxis |
| GO:0055098 | 0.03341 | 39.34018 | 0 | 1 | 4 | response to low-density lipoprotein particle stimulus |
| GO:0060244 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of cell proliferation involved in contact inhibition |
| GO:0061054 | 0.03341 | 39.34018 | 0 | 1 | 4 | dermatome development |
| GO:0061183 | 0.03341 | 39.34018 | 0 | 1 | 4 | regulation of dermatome development |
| GO:0071611 | 0.03341 | 39.34018 | 0 | 1 | 4 | granulocyte colony-stimulating factor production |
| GO:0072093 | 0.03341 | 39.34018 | 0 | 1 | 4 | metanephric renal vesicle formation |
| GO:0097026 | 0.03341 | 39.34018 | 0 | 1 | 4 | dendritic cell dendrite assembly |
| GO:0097350 | 0.03341 | 39.34018 | 0 | 1 | 4 | neutrophil clearance |
| GO:0099550 | 0.03341 | 39.34018 | 0 | 1 | 4 | trans-synaptic signaling, modulating synaptic transmission |
| GO:1901256 | 0.03341 | 39.34018 | 0 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:1901842 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of high voltage-gated calcium channel activity |
| GO:1903237 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of leukocyte tethering or rolling |
| GO:1905771 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of mesodermal cell differentiation |
| GO:1905903 | 0.03341 | 39.34018 | 0 | 1 | 4 | negative regulation of mesoderm formation |
| GO:2001280 | 0.03341 | 39.34018 | 0 | 1 | 4 | positive regulation of unsaturated fatty acid biosynthetic process |
| GO:0003013 | 0.03346 | 2.12573 | 4 | 9 | 522 | circulatory system process |
| GO:0099536 | 0.03358 | 2.03414 | 5 | 10 | 607 | synaptic signaling |
| GO:0099537 | 0.03358 | 2.03414 | 5 | 10 | 607 | trans-synaptic signaling |
| GO:0048705 | 0.03368 | 2.91057 | 2 | 5 | 211 | skeletal system morphogenesis |
| GO:0051896 | 0.03368 | 2.91057 | 2 | 5 | 211 | regulation of protein kinase B signaling |
| GO:0007605 | 0.03401 | 3.41538 | 1 | 4 | 144 | sensory perception of sound |
| GO:0070665 | 0.03401 | 3.41538 | 1 | 4 | 144 | positive regulation of leukocyte proliferation |
| GO:0043065 | 0.03422 | 2.02710 | 5 | 10 | 609 | positive regulation of apoptotic process |
| GO:0012501 | 0.03437 | 1.55558 | 17 | 25 | 2031 | programmed cell death |
| GO:0048592 | 0.03476 | 3.39096 | 1 | 4 | 145 | eye morphogenesis |
| GO:0060402 | 0.03476 | 3.39096 | 1 | 4 | 145 | calcium ion transport into cytosol |
| GO:0019538 | 0.03517 | 1.37815 | 50 | 61 | 5917 | protein metabolic process |
| GO:0010742 | 0.03524 | 7.18955 | 0 | 2 | 35 | macrophage derived foam cell differentiation |
| GO:0043277 | 0.03524 | 7.18955 | 0 | 2 | 35 | apoptotic cell clearance |
| GO:0045687 | 0.03524 | 7.18955 | 0 | 2 | 35 | positive regulation of glial cell differentiation |
| GO:0046329 | 0.03524 | 7.18955 | 0 | 2 | 35 | negative regulation of JNK cascade |
| GO:0090077 | 0.03524 | 7.18955 | 0 | 2 | 35 | foam cell differentiation |
| GO:0022602 | 0.03540 | 4.35772 | 1 | 3 | 85 | ovulation cycle process |
| GO:0043506 | 0.03540 | 4.35772 | 1 | 3 | 85 | regulation of JUN kinase activity |
| GO:0045621 | 0.03540 | 4.35772 | 1 | 3 | 85 | positive regulation of lymphocyte differentiation |
| GO:0051050 | 0.03545 | 1.79234 | 8 | 14 | 970 | positive regulation of transport |
| GO:0030100 | 0.03547 | 2.86829 | 2 | 5 | 214 | regulation of endocytosis |
| GO:0071496 | 0.03586 | 2.55802 | 2 | 6 | 288 | cellular response to external stimulus |
| GO:0030900 | 0.03619 | 2.35028 | 3 | 7 | 366 | forebrain development |
| GO:0043068 | 0.03622 | 2.00627 | 5 | 10 | 615 | positive regulation of programmed cell death |
| GO:0055067 | 0.03627 | 3.34315 | 1 | 4 | 147 | monovalent inorganic cation homeostasis |
| GO:0090092 | 0.03668 | 2.84076 | 2 | 5 | 216 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0051707 | 0.03669 | 1.82477 | 7 | 13 | 883 | response to other organism |
| GO:0002791 | 0.03679 | 2.19673 | 4 | 8 | 448 | regulation of peptide secretion |
| GO:0030031 | 0.03707 | 2.08384 | 4 | 9 | 532 | cell projection assembly |
| GO:0032205 | 0.03710 | 6.97769 | 0 | 2 | 36 | negative regulation of telomere maintenance |
| GO:0050919 | 0.03710 | 6.97769 | 0 | 2 | 36 | negative chemotaxis |
| GO:0098815 | 0.03710 | 6.97769 | 0 | 2 | 36 | modulation of excitatory postsynaptic potential |
| GO:1901385 | 0.03710 | 6.97769 | 0 | 2 | 36 | regulation of voltage-gated calcium channel activity |
| GO:1901564 | 0.03712 | 1.36416 | 59 | 70 | 6962 | organonitrogen compound metabolic process |
| GO:0040012 | 0.03726 | 1.82036 | 7 | 13 | 885 | regulation of locomotion |
| GO:0070663 | 0.03730 | 2.82720 | 2 | 5 | 217 | regulation of leukocyte proliferation |
| GO:0071453 | 0.03730 | 2.82720 | 2 | 5 | 217 | cellular response to oxygen levels |
| GO:0030510 | 0.03753 | 4.25347 | 1 | 3 | 87 | regulation of BMP signaling pathway |
| GO:0048013 | 0.03753 | 4.25347 | 1 | 3 | 87 | ephrin receptor signaling pathway |
| GO:0043207 | 0.03754 | 1.81817 | 7 | 13 | 886 | response to external biotic stimulus |
| GO:0097191 | 0.03793 | 2.81376 | 2 | 5 | 218 | extrinsic apoptotic signaling pathway |
| GO:0070482 | 0.03849 | 2.31731 | 3 | 7 | 371 | response to oxygen levels |
| GO:0000302 | 0.03856 | 2.80045 | 2 | 5 | 219 | response to reactive oxygen species |
| GO:0030316 | 0.03863 | 4.20319 | 1 | 3 | 88 | osteoclast differentiation |
| GO:0034405 | 0.03901 | 6.77793 | 0 | 2 | 37 | response to fluid shear stress |
| GO:0071542 | 0.03901 | 6.77793 | 0 | 2 | 37 | dopaminergic neuron differentiation |
| GO:0035567 | 0.03941 | 3.25142 | 1 | 4 | 151 | non-canonical Wnt signaling pathway |
| GO:0001503 | 0.03943 | 2.30437 | 3 | 7 | 373 | ossification |
| GO:0008219 | 0.03945 | 1.52044 | 18 | 26 | 2160 | cell death |
| GO:0015711 | 0.03972 | 2.16143 | 4 | 8 | 455 | organic anion transport |
| GO:0002690 | 0.03973 | 4.15407 | 1 | 3 | 89 | positive regulation of leukocyte chemotaxis |
| GO:0002275 | 0.03974 | 2.05546 | 5 | 9 | 539 | myeloid cell activation involved in immune response |
| GO:0034612 | 0.04067 | 2.47759 | 3 | 6 | 297 | response to tumor necrosis factor |
| GO:0090630 | 0.04086 | 4.10608 | 1 | 3 | 90 | activation of GTPase activity |
| GO:0003009 | 0.04096 | 6.58927 | 0 | 2 | 38 | skeletal muscle contraction |
| GO:0046676 | 0.04096 | 6.58927 | 0 | 2 | 38 | negative regulation of insulin secretion |
| GO:1902042 | 0.04096 | 6.58927 | 0 | 2 | 38 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0002457 | 0.04158 | 29.50342 | 0 | 1 | 5 | T cell antigen processing and presentation |
| GO:0006269 | 0.04158 | 29.50342 | 0 | 1 | 5 | DNA replication, synthesis of RNA primer |
| GO:0008582 | 0.04158 | 29.50342 | 0 | 1 | 5 | regulation of synaptic growth at neuromuscular junction |
| GO:0009256 | 0.04158 | 29.50342 | 0 | 1 | 5 | 10-formyltetrahydrofolate metabolic process |
| GO:0010641 | 0.04158 | 29.50342 | 0 | 1 | 5 | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0010841 | 0.04158 | 29.50342 | 0 | 1 | 5 | positive regulation of circadian sleep/wake cycle, wakefulness |
| GO:0010891 | 0.04158 | 29.50342 | 0 | 1 | 5 | negative regulation of sequestering of triglyceride |
| GO:0010968 | 0.04158 | 29.50342 | 0 | 1 | 5 | regulation of microtubule nucleation |
| GO:0016199 | 0.04158 | 29.50342 | 0 | 1 | 5 | axon midline choice point recognition |
| GO:0030885 | 0.04158 | 29.50342 | 0 | 1 | 5 | regulation of myeloid dendritic cell activation |
| GO:0031339 | 0.04158 | 29.50342 | 0 | 1 | 5 | negative regulation of vesicle fusion |
| GO:0031547 | 0.04158 | 29.50342 | 0 | 1 | 5 | brain-derived neurotrophic factor receptor signaling pathway |
| GO:0033029 | 0.04158 | 29.50342 | 0 | 1 | 5 | regulation of neutrophil apoptotic process |
| GO:0033625 | 0.04158 | 29.50342 | 0 | 1 | 5 | positive regulation of integrin activation |
| GO:0035811 | 0.04158 | 29.50342 | 0 | 1 | 5 | negative regulation of urine volume |
| GO:0046813 | 0.04158 | 29.50342 | 0 | 1 | 5 | receptor-mediated virion attachment to host cell |
| GO:0048496 | 0.04158 | 29.50342 | 0 | 1 | 5 | maintenance of animal organ identity |
| GO:0060385 | 0.04158 | 29.50342 | 0 | 1 | 5 | axonogenesis involved in innervation |
| GO:0061056 | 0.04158 | 29.50342 | 0 | 1 | 5 | sclerotome development |
| GO:0070100 | 0.04158 | 29.50342 | 0 | 1 | 5 | negative regulation of chemokine-mediated signaling pathway |
| GO:0071205 | 0.04158 | 29.50342 | 0 | 1 | 5 | protein localization to juxtaparanode region of axon |
| GO:0071504 | 0.04158 | 29.50342 | 0 | 1 | 5 | cellular response to heparin |
| GO:0072675 | 0.04158 | 29.50342 | 0 | 1 | 5 | osteoclast fusion |
| GO:0090074 | 0.04158 | 29.50342 | 0 | 1 | 5 | negative regulation of protein homodimerization activity |
| GO:0090245 | 0.04158 | 29.50342 | 0 | 1 | 5 | axis elongation involved in somitogenesis |
| GO:0097327 | 0.04158 | 29.50342 | 0 | 1 | 5 | response to antineoplastic agent |
| GO:1900425 | 0.04158 | 29.50342 | 0 | 1 | 5 | negative regulation of defense response to bacterium |
| GO:1900748 | 0.04158 | 29.50342 | 0 | 1 | 5 | positive regulation of vascular endothelial growth factor signaling pathway |
| GO:1901509 | 0.04158 | 29.50342 | 0 | 1 | 5 | regulation of endothelial tube morphogenesis |
| GO:1901552 | 0.04158 | 29.50342 | 0 | 1 | 5 | positive regulation of endothelial cell development |
| GO:1903142 | 0.04158 | 29.50342 | 0 | 1 | 5 | positive regulation of establishment of endothelial barrier |
| GO:1903826 | 0.04158 | 29.50342 | 0 | 1 | 5 | arginine transmembrane transport |
| GO:2001188 | 0.04158 | 29.50342 | 0 | 1 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:2001286 | 0.04158 | 29.50342 | 0 | 1 | 5 | regulation of caveolin-mediated endocytosis |
| GO:0050770 | 0.04187 | 3.18583 | 1 | 4 | 154 | regulation of axonogenesis |
| GO:0015908 | 0.04200 | 4.05919 | 1 | 3 | 91 | fatty acid transport |
| GO:0043154 | 0.04200 | 4.05919 | 1 | 3 | 91 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0050830 | 0.04200 | 4.05919 | 1 | 3 | 91 | defense response to Gram-positive bacterium |
| GO:0099024 | 0.04200 | 4.05919 | 1 | 3 | 91 | plasma membrane invagination |
| GO:0050789 | 0.04214 | 1.39393 | 97 | 107 | 11437 | regulation of biological process |
| GO:0072659 | 0.04249 | 2.72311 | 2 | 5 | 225 | protein localization to plasma membrane |
| GO:0050864 | 0.04270 | 3.16454 | 1 | 4 | 155 | regulation of B cell activation |
| GO:0030049 | 0.04294 | 6.41081 | 0 | 2 | 39 | muscle filament sliding |
| GO:0033275 | 0.04294 | 6.41081 | 0 | 2 | 39 | actin-myosin filament sliding |
| GO:0033628 | 0.04294 | 6.41081 | 0 | 2 | 39 | regulation of cell adhesion mediated by integrin |
| GO:0038111 | 0.04294 | 6.41081 | 0 | 2 | 39 | interleukin-7-mediated signaling pathway |
| GO:0061028 | 0.04294 | 6.41081 | 0 | 2 | 39 | establishment of endothelial barrier |
| GO:1905517 | 0.04294 | 6.41081 | 0 | 2 | 39 | macrophage migration |
| GO:0048010 | 0.04315 | 4.01334 | 1 | 3 | 92 | vascular endothelial growth factor receptor signaling pathway |
| GO:0071347 | 0.04315 | 4.01334 | 1 | 3 | 92 | cellular response to interleukin-1 |
| GO:0051924 | 0.04317 | 2.71063 | 2 | 5 | 226 | regulation of calcium ion transport |
| GO:0003205 | 0.04355 | 3.14354 | 1 | 4 | 156 | cardiac chamber development |
| GO:0010950 | 0.04355 | 3.14354 | 1 | 4 | 156 | positive regulation of endopeptidase activity |
| GO:0015718 | 0.04355 | 3.14354 | 1 | 4 | 156 | monocarboxylic acid transport |
| GO:0045619 | 0.04355 | 3.14354 | 1 | 4 | 156 | regulation of lymphocyte differentiation |
| GO:0060491 | 0.04355 | 3.14354 | 1 | 4 | 156 | regulation of cell projection assembly |
| GO:0042060 | 0.04379 | 2.01618 | 5 | 9 | 549 | wound healing |
| GO:0051046 | 0.04392 | 1.87140 | 6 | 11 | 725 | regulation of secretion |
| GO:0040013 | 0.04409 | 2.42668 | 3 | 6 | 303 | negative regulation of locomotion |
| GO:0030041 | 0.04441 | 3.12281 | 1 | 4 | 157 | actin filament polymerization |
| GO:0060401 | 0.04441 | 3.12281 | 1 | 4 | 157 | cytosolic calcium ion transport |
| GO:0030204 | 0.04495 | 6.24174 | 0 | 2 | 40 | chondroitin sulfate metabolic process |
| GO:0042088 | 0.04495 | 6.24174 | 0 | 2 | 40 | T-helper 1 type immune response |
| GO:0098760 | 0.04495 | 6.24174 | 0 | 2 | 40 | response to interleukin-7 |
| GO:0098761 | 0.04495 | 6.24174 | 0 | 2 | 40 | cellular response to interleukin-7 |
| GO:0042110 | 0.04510 | 2.10342 | 4 | 8 | 467 | T cell activation |
| GO:0007411 | 0.04524 | 2.67386 | 2 | 5 | 229 | axon guidance |
| GO:1990823 | 0.04551 | 3.92468 | 1 | 3 | 94 | response to leukemia inhibitory factor |
| GO:1990830 | 0.04551 | 3.92468 | 1 | 3 | 94 | cellular response to leukemia inhibitory factor |
| GO:0046942 | 0.04647 | 2.39386 | 3 | 6 | 307 | carboxylic acid transport |
| GO:0009719 | 0.04652 | 1.59063 | 13 | 19 | 1490 | response to endogenous stimulus |
| GO:0097485 | 0.04665 | 2.64988 | 2 | 5 | 231 | neuron projection guidance |
| GO:0002062 | 0.04671 | 3.88179 | 1 | 3 | 95 | chondrocyte differentiation |
| GO:0031952 | 0.04700 | 6.08134 | 0 | 2 | 41 | regulation of protein autophosphorylation |
| GO:0032459 | 0.04700 | 6.08134 | 0 | 2 | 41 | regulation of protein oligomerization |
| GO:0030177 | 0.04703 | 3.06222 | 1 | 4 | 160 | positive regulation of Wnt signaling pathway |
| GO:0051345 | 0.04763 | 1.84443 | 6 | 11 | 735 | positive regulation of hydrolase activity |
| GO:0002286 | 0.04793 | 3.83983 | 1 | 3 | 96 | T cell activation involved in immune response |
| GO:0007229 | 0.04793 | 3.83983 | 1 | 3 | 96 | integrin-mediated signaling pathway |
| GO:0051052 | 0.04864 | 2.19401 | 3 | 7 | 391 | regulation of DNA metabolic process |
| GO:0031960 | 0.04883 | 3.02310 | 1 | 4 | 162 | response to corticosteroid |
| GO:0002832 | 0.04908 | 5.92897 | 0 | 2 | 42 | negative regulation of response to biotic stimulus |
| GO:0010883 | 0.04908 | 5.92897 | 0 | 2 | 42 | regulation of lipid storage |
| GO:0045429 | 0.04908 | 5.92897 | 0 | 2 | 42 | positive regulation of nitric oxide biosynthetic process |
| GO:0050654 | 0.04908 | 5.92897 | 0 | 2 | 42 | chondroitin sulfate proteoglycan metabolic process |
| GO:1904407 | 0.04908 | 5.92897 | 0 | 2 | 42 | positive regulation of nitric oxide metabolic process |
| GO:0001657 | 0.04916 | 3.79876 | 1 | 3 | 97 | ureteric bud development |
| GO:0043534 | 0.04916 | 3.79876 | 1 | 3 | 97 | blood vessel endothelial cell migration |
| GO:0051962 | 0.04944 | 2.06186 | 4 | 8 | 476 | positive regulation of nervous system development |
| GO:0000820 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of glutamine family amino acid metabolic process |
| GO:0002885 | 0.04969 | 23.60137 | 0 | 1 | 6 | positive regulation of hypersensitivity |
| GO:0003105 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of glomerular filtration |
| GO:0007185 | 0.04969 | 23.60137 | 0 | 1 | 6 | transmembrane receptor protein tyrosine phosphatase signaling pathway |
| GO:0009996 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of cell fate specification |
| GO:0010840 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of circadian sleep/wake cycle, wakefulness |
| GO:0010871 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of receptor biosynthetic process |
| GO:0010887 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of cholesterol storage |
| GO:0015809 | 0.04969 | 23.60137 | 0 | 1 | 6 | arginine transport |
| GO:0015942 | 0.04969 | 23.60137 | 0 | 1 | 6 | formate metabolic process |
| GO:0022028 | 0.04969 | 23.60137 | 0 | 1 | 6 | tangential migration from the subventricular zone to the olfactory bulb |
| GO:0031392 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of prostaglandin biosynthetic process |
| GO:0032687 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of interferon-alpha production |
| GO:0032960 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of inositol trisphosphate biosynthetic process |
| GO:0033239 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of cellular amine metabolic process |
| GO:0035814 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of renal sodium excretion |
| GO:0042320 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of circadian sleep/wake cycle, REM sleep |
| GO:0042746 | 0.04969 | 23.60137 | 0 | 1 | 6 | circadian sleep/wake cycle, wakefulness |
| GO:0044340 | 0.04969 | 23.60137 | 0 | 1 | 6 | canonical Wnt signaling pathway involved in regulation of cell proliferation |
| GO:0045627 | 0.04969 | 23.60137 | 0 | 1 | 6 | positive regulation of T-helper 1 cell differentiation |
| GO:0046880 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of follicle-stimulating hormone secretion |
| GO:0046881 | 0.04969 | 23.60137 | 0 | 1 | 6 | positive regulation of follicle-stimulating hormone secretion |
| GO:0048050 | 0.04969 | 23.60137 | 0 | 1 | 6 | post-embryonic eye morphogenesis |
| GO:0051136 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of NK T cell differentiation |
| GO:0051902 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of mitochondrial depolarization |
| GO:0060331 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of response to interferon-gamma |
| GO:0060336 | 0.04969 | 23.60137 | 0 | 1 | 6 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0060526 | 0.04969 | 23.60137 | 0 | 1 | 6 | prostate glandular acinus morphogenesis |
| GO:0060527 | 0.04969 | 23.60137 | 0 | 1 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
| GO:0070459 | 0.04969 | 23.60137 | 0 | 1 | 6 | prolactin secretion |
| GO:0071503 | 0.04969 | 23.60137 | 0 | 1 | 6 | response to heparin |
| GO:0072674 | 0.04969 | 23.60137 | 0 | 1 | 6 | multinuclear osteoclast differentiation |
| GO:2000354 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of ovarian follicle development |
| GO:2001279 | 0.04969 | 23.60137 | 0 | 1 | 6 | regulation of unsaturated fatty acid biosynthetic process |